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Data Mining 
 
Data mining can be defined as the nontrivial extraction of implicit, previously 
unknown and potentially useful information from data [1]. 
Different data mining methods and techniques have been developed. The 
classification elaborated by Gibert et al. [2] is displayed in figure 1.  
 
 
Figure 1. Classification of Data Mining Techniques. 
 
 
The higher level division takes into account the basic distinction between having 
or not having a reference variable to be explained (response variable). The left 
part of the organigram refers to non-supervised methods, without a response 
variable. The main goal of these methods is a better knowledge of the target 
phenomenon and a description is sufficient as a result. The right part of the 
organigram refers to supervised models oriented to recognition, where a 
response variable is to be explained and prediction is claimed. At a second 
level, for methods oriented to description, the main division regards the interest 
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of describing relationships between objects (rows of data matrix), which are 
labelled as descriptive methods, or describing relationships between variables 
(columns of data matrix), labelled as associative methods. For methods 
oriented to prediction, the main distinction regards the nature of the response 
variable. While discriminant methods explain or predict qualitative variables, the 
classical predictive methods refer to quantitative response variables. Because 
of variety, discriminant models include a further level of subdivision. Rule-based 
reasoning methods provide an explicit knowledge model, which can be 
expressed by formal rules or not, to be applied for further prediction. In case-
based reasoning methods the predictive model is implicit in historical data. The 
third option is a mixture between a prior explicit knowledge model and iterative 
refinements based on future data. Finally, in the presented conceptual map of 
Data Mining techniques, different colours have been used for methods coming 
from the field of Artificial Intelligence or Statistics. 
The choice of the data mining technique to be used depends by the specific 
application. 
Data mining is used in a many research areas, including mathematics, 
cybernetics, marketing and medicine. 
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Data Mining in Biomedicine 
 
Data mining can be applied in biomedicine for different purposes. Traditionally, 
it focused on clinical applications with the main purpose to derive models using 
patient-specific information to predict a patient’s diagnosis, prognosis, or any 
other outcome of interest and to thereby support clinical decision-making [3]. 
Other tasks addressed with clinical data mining are the detection of data 
artifacts [4] and adverse events [5], discovering homogeneous subgroups of 
patients [6], and extracting meaningful features from signal and image data [7]. 
In recent years, biomedical data mining has received a strong impulse from 
research in molecular biology. In this field, datasets fall into different classes: i) 
sequence data, often represented by a collection of single nucleotide 
polymorphisms [8], ii) gene expression data, which can be measured with DNA 
microarrays to obtain a snapshot of the activity of all genes in one tissue at a 
given time or under a particular condition [9], iii) protein expression data, which 
can include a complete set of protein profiles obtained with mass spectra 
technologies or a few protein markers [10], and iv) microRNA expression 
profiles, which can be measured with microRNA microarrays [11]. 
 
 
This thesis is focused on Data Mining in Biomedicine. However, two completely 
different subjects are treated and two different approaches are implemented. 
Therefore, this thesis has been divided in two separate and independent parts. 
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Abstract 
 
Bayesian Networks represent one of the most successful tools for medical 
diagnosis and therapies follow-up.  
Formally, a Bayesian Network (BN) is a probabilistic graphical model that 
represents a set of random variables and their conditional dependencies via a 
directed acyclic graph. 
An algorithm for Bayesian network structure learning that is a variation of the 
standard search-and-score approach is presented. The proposed approach 
overcomes the creation of redundant network structures that may include non 
significant connections between variables. In particular, the algorithm finds 
which relationships between the variables must be prevented, by exploiting the 
binarization of a square matrix containing the mutual information (MI) among all 
pairs of variables. Four different binarization methods are implemented. The MI 
binary matrix is exploited as a pre-conditioning step for the subsequent greedy 
search procedure that optimizes the network score, reducing the number of 
possible search paths in the greedy search procedure. This approach has been 
tested on four different datasets and compared against the standard search-
and-score algorithm as implemented in the DEAL package, with successful 
results. 
Moreover, a comparison among different network scores has been performed. 
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Introduction 
 
The practice of medicine is fraught with uncertainty. In fact, the physicians are 
often not sure of a diagnosis, which tests to perform, which treatment to select, 
or what a patient's prognosis is. This uncertainty does not prevent the 
physicians from doing what is right for a particular patient; that is, patient 
outcomes are often excellent despite this uncertainty, because people are adept 
at managing uncertainty [1]. Bayesian Networks constitute a widely accepted 
formalism for representing knowledge with uncertainty and efficient reasoning 
[2]. For this reason, they are used in biomedicine and health-care to support 
different types of problem solving, such as diagnostic reasoning, that is 
constructing a hypothesis about the disease the patient is suffering from, based 
upon a set of indirect observations from diagnostic tests; prognostic reasoning, 
that is making a prediction about what will happen in the future, and discovery 
of functional interactions among the variables of interest [1, 3]. 
Over the years, there has been a strong generation of medical databases, and 
a Bayesian Network can be learned directly from the data. The problem of 
building such a BN can be separated into two subtasks, structure learning, that 
is to identify the topology of the network, and parameter learning, that is to 
identify the numerical parameters for a given network topology [4]. This work is 
focused upon structure learning. Structure learning of Bayesian Networks has 
been first implemented in R by Bøttcher and Dethlefsen, who wrote the DEAL 
package [5]. In DEAL a BDe (Bayesian with Dirichlet prior and Equivalence) 
score extended to Conditional Gaussian-Bayesian Networks (CG-BNs) [6] is 
implemented to evaluate how well a given network matches the data and a 
Greedy Search algorithm with random restart [7] is used as the search engine 
optimizing the BDe score. However, the metric implemented in DEAL often 
converges to a complete network, overestimating the number of connections 
among variables.  
The main goal of the first part of this thesis has been the development of a new 
method for BNs structure learning that uses the same basis approach of DEAL 
but applies a strategy to overcome its limits preventing the inference of too 
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many connections [8, 9, 10]. The strategy is based on the construction of a 
skeleton of a Bayesian Network. This is an undirected graph, whose arcs 
represent the only admitted connections. The skeleton is used to
 
constrain the 
directed acyclic graphs considered during the search-and-score phase, that is 
to reduce the  search space. The graphs which contain any of the arc absent  in 
the skeleton  are disregarded in the search procedure.  
Moreover, this thesis has had two secondary aims: 
 to offer a quantifiable description of the topology of the inferred 
networks; 
 to compare the BDe score used in DEAL as well as in the developed 
strategy with other network scores available in literature. 
 
The remainder of this thesis is organized as follows.  
Chapter 1 provides background on Bayesian Networks and describes the 
existing literature on structure learning methods.  
Chapter 2 represents the nucleus of this part of my thesis, because it describes 
the new implemented strategy for structure learning.  
Chapter 3 describes the experimental procedure developed to evaluate the 
performance of  the developed strategy and to compare it to DEAL.  
Chapter 4 reports all the results obtained regarding the developed algorithm.  
Chapter 5 is centred on the algorithm developed to describe the network’s 
topology. 
Chapter 6 reports the results concerning the comparison among different 
network scores.  
Finally, the last chapter draws together and summarizes the major conclusions 
of this study. 
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1 Bayesian Networks 
 
1.1 Introduction 
Some reasons for choosing Bayesian Networks as a vehicle for one’s ideas are: 
1. they are graphical models, capable of displaying relationships clearly and 
intuitively; 
2. they are directional, thus being capable of representing cause-effect 
relationships; 
3. they can handle uncertainty; 
4. they handle uncertainty though the established theory of probability; 
5. they can be used to represent indirect in addition to direct causation. 
Since the beginning of the 1990s, they have been used for medical applications. 
In fact, the BN formalism offers a natural way to represent the uncertainties 
involved in medicine when dealing with diagnosis, treatment selection, planning, 
and prediction of prognosis [1, 3]. 
 
 
1.2 The BN formalism 
A Bayesian Network (BN) is a graphical model that represents a joint probability 
distribution over a set of random variables [11]. It is used to represent 
knowledge about an uncertain domain [12, 13]. A BN comprises a qualitative 
and a quantitative component. 
The qualitative part of a BN represents structural information about a problem 
domain. It is a directed acyclic graph (DAG), which means that the edges have 
a direction and that there are no cyclic paths (loops). The nodes in the graph 
represent the random variables in the domain and the edges represent direct 
dependences among the variables and are drawn by arrows between nodes. In 
particular, an edge from node Xi  to node Xj  indicates that the variable Xi 
'influences' Xj. Node Xi  is then referred to as a 'parent' of Xj and, similarly, Xj is 
referred to as the 'child' of Xi [14]. The graph G encodes independence 
assumptions, by which each variable is independent of its non-descendents 
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given its parents in G. For the general conditional independence in a Bayesian 
network, Pearl [13] proposed the concept of d-separation. The definition of d-
separation is as follows: two sets of nodes Xi and Xj are d-separated in 
Bayesian networks by a third set Xk (excluding Xi and Xj) if and only if every 
path between Xi and Xj is “blocked”, where the term “blocked” means that there 
is an intermediate variable Xv (distinct from Xi and Xj) such that the connection 
through Xv is “tail-to-tail” or “tail-to-head” and Xv is instantiated or the connection 
through Xv is “head-to-head” and neither Xv nor any of Xv’s descendants have 
received evidence. The graph patterns are shown in Figure 1.1.  
 
 
Figure 1.1. Patterns for paths through a node: tail-to-tail or diverging pattern (a), 
tail-to-hrad or serial pattern (b), and head-to-head or converging pattern (c). 
 
The minimal set of nodes which d-separates node Xi from all other nodes is Xi 's 
Markov blanket (MB). The Markov blanket MB(Xi) of node Xi in a Bayesian 
network is the set of nodes composed of Xi 's parents, its children, and its 
children's parents [15]. 
The quantitative component allows us to introduce uncertainty into the model 
and is a set of numerical parameters, which represent conditional probability 
distributions (CPD). The parameters are described in a manner which is 
consistent with a Markovian property, so that to each variable Xi with parents 
pa(Xi), there is attached a local probability distribution, p(Xi/pa(Xi)), that 
depends only on its parents. For discrete random variables, this conditional 
probability is often represented by a table called conditional probability table 
(CPT) [16, 17], listing the local probabilities that a child node takes on each of 
the feasible values and for each combination of values of its parents. If Xi has 
no parent, then p(Xi/pa(Xi)) equals p(Xi) and the table gives the marginal 
probabilities of the node. Figure 1.2 shows simple Bayesian Network constituted 
by three variables, each one with two possible values, and the corresponding 
conditional probability tables. 
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Figure 1.2. Bayesian Network with Model Parameters in the Form of CPTs. 
 
For BNs which use continuous variables, conditional probability densities are 
used in a similar way to CPTs [18]. Figure 1.3 presents a simple BN which 
introduces the concept of using continuous variables. The usual notation is to 
use squares for discrete nodes and circles for continuous nodes. A continuous 
node, B, with a discrete parent A which can have k states leads to a model of 
the continuous data using k Gaussian distributions. Thus, given that A is in state 
ai, the likelihood of a value of B may be inferred, or, alternatively, given a value 
b for variable B, the probability that variable A is in state ai may be inferred. 
Parameters for the Gaussians (or other distributions) can be learned from 
training data. θB is the parameter set that encodes the model for B in terms of 
three Gaussians, one for each of the possible states of A. The mean µi and 
standard deviation σi are the parameters for the Gaussian distribution which 
models p(b/ai). In a similar way, regression models for CPDs of continuous 
variables with continuous parents may be used. In this case, θB=P(B/A) ~N(c + 
ma, σ2) i.e., the CPD for B is a Gaussian distribution with a mean dependent on 
the value of A=a, with constants m and c are determined by regression of B on 
A. 
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Figure 1.3. Illustration of Model Parameters for Two-Node Bayesian Network. 
 
 
1.3 Joint probability distribution 
The joint distribution of a collection of variables can be determined uniquely by 
the local parameters using: 
 
))(/(),....,,()(
1
21 ∏
=
==
n
i
iin XpaXpXXXpXp        (1.1) 
 
where n is the number of variables. 
 
 
1.4 Learning Bayesian Networks 
The problem of building such a BN can be separated into two subtasks, 
structure learning, that is to identify the topology of the network, and parameter 
learning, that is to identify the numerical parameters (conditional probabilities) 
for a given network topology. 
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This work is focused upon structure learning. There are two main different 
approaches proposed in the literature to accomplish this objective: methods 
based on conditional independence tests (also called constraint-based 
methods) and methods based on scoring functions and search.  
 
 
1.5 Structure Learning: Constraint-based methods 
The constraint-based methods perform conditional independence tests to find 
the dependence and independence relationships among the variables in the 
domain and attempt to define the network that represents these relationships.  
A conditional independence (CI) test checks the validity of an independence 
assertion I(X,Z,Y) by performing a statistical hypothesis testing procedure [19, 
20]. To begin with, the conditional independence assertion (i.e. I(X;Z;Y)) is 
modeled as the null hypothesis. 
Suppose that the likelihood-ratio χ2 test is used, the χ2 statistics is calculated 
by: 
 
)(),(
),,(
log),,(2
,,
2
zxPzyP
zyxP
zyxPg
zyx
∑−=
          (1.2) 
 
If the number of possible instantiations of the variables X, Y, and Z are 
respectively vX, vY, and vZ, then χ2 follows a distribution with (vX - 1) X (vY - 1) X 
vZ degree of freedom. The p-value is obtained checking the computed g2 
against the distribution. If the p-value is less than a predefined cutoff value α, 
the test shows strong evidence to reject the hypothesis; otherwise, the 
hypothesis cannot be rejected. This test will be well described later. 
In order to use the results to reconstruct the structure, several assumptions 
have to be made:  
- causal sufficiency assumption: there aren’t common unobserved (also known 
as hidden or latent) variables in the domain that are parent of one or more 
observed variables of the domain; 
- Markov assumption: given a Bayesian network model B, any variable is 
independent of all its nondescendants in B, given its parents; 
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- faithfulness assumption: a BN graph G and a probability distribution P are 
faithful to one another if every one and all independence relations valid in P are 
those entailed by the Markov assumption on G. 
With these assumptions in place, one can ascertain the existence of an edge 
between two variables, or the direction of that link, though the latter is only 
being possible in certain cases.  
Some representative algorithms in this category are SGS algorithm, IC 
algorithm, PC algorithm, and GS algorithm. 
 
1.5.1 SGS Algorithm 
The pseudocode of the SGS (Spirtes, Glymour, and Scheines) algorithm [20] is 
shown in Figure 1.4.  
 
 
Figure 1.4. Pseudocode of the SGS algorithm. 
 
The algorithm begins with a completely connected undirected graph. In other 
words, dependence between every pair of variables is assumed. Then, CI tests 
between all pairs of connected nodes are conducted. When two nodes X and Y 
are found to be conditionally independent given Z, the undirected edge between 
them is removed so that I(X, Z, Y) is not violated. When no more edges can be 
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removed, the undirected edges in the graph are oriented according to some 
rules, which conform with the conditional independence relations previously 
discovered. This produces the final Bayesian Network structure. The 
computational cost of SGS is exponential in the number of nodes in the graph 
because it has considered all the possible subsets of nodes that can be 
conditioned on. Thus the algorithm does not scale to large graphs. 
 
1.5.2 PC algorithm 
Peter Spirtes and Clark Glymour developed a more efficient constraint-based 
algorithm, namely the PC algorithm [20]. It conducts independence tests 
between all the variable pairs conditioned on the subsets of other node 
variables that are sorted by their sizes, from small to large. The subsets whose 
sizes are larger than a given threshold are not considered. The PC algorithm 
can be applied on graphs with hundreds of node variables. However, when the 
number of nodes becomes even larger, the PC algorithm does not scale well 
either. 
 
1.5.3 IC (Inductive Causation) algorithm 
The IC (Inductive Causation) algorithm [13] outputs a pattern of the target 
Bayesian Network. Every Bayesian Network G defines an equivalence class CG 
of Bayesian Networks that have the same set of d-separation relations. A 
pattern G’ of G is a partially directed graph with the skeleton of G such that an 
arrow is in G’ if and only if it is in every Bayesian Network in CG. The main steps 
of the IC algorithm are sketched in Figure 1.5. 
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Figure 1.5. Outline of the IC algorithm. 
 
1.5.4 Grow-Shrinkage (GS) algorithm  
The Grow-Shrinkage (GS) algorithm [21] allows to learn Bayesian Networks 
with thousands of variables. Its running time is better than the PC algorithm, 
although still exponential in the worst case. However its main advantage is the 
use of the concept of the variable’ Markov Blanket, which makes it easier to 
evaluate in a semi-automated context where prior information is available by an 
expert who can verify the results of the independence tests involved. In GS 
algorithm, two phases are used to identify the estimated Markov blanket: 
growing and shrinking one, hence its name. Starting from an empty set S, the 
growing phase adds variables to S as long as they are dependent with X given 
the current contents of S. The idea behind this is simple: as long as the Markov 
blanket property of X is violated (i.e. there exists a variable in U that is 
dependent on X given the current S), it is added to the current set S until there 
are no more such variables. In this process however, there may be some 
variables added to S that are really outside the blanket. Such variables are 
those that have been rendered independent from X at a later point when 
intermediate (d-separating) nodes of the underlying BN were added to S. This 
observation motivates the shrinking phase, which identifies and removes these 
variables. Then the algorithm tries to identify the parents and children for each 
variable from the estimated Markov blanket and tries to orient the edges. The 
Meloni Antonella                                                                                               Part I 
 
23 
main steps of the GS algorithm are indicated in Figure 1.6. The time cost of GS 
is O(P2) where P represents the number of nodes.  
 
 
Figure 1.6. GS algorithm. 
 
Other algorithms exist in the literature that do not make use of independence 
tests but take into account d-separation in order to discover structure from data. 
Cheng et al. [4] for example have used mutual information instead of conditional 
independence tests. The algorithm requires the ordering of the variables to be 
given to the algorithm in advance. 
 
1.5.5 Problems of the dependency analysis approach 
In general, the dependency analysis approach has three problems. First, to 
determine whether two nodes are dependent is time consuming. In the worst 
case, all possible combinations of the conditioning set need to be examined and 
this would require an exponential number of tests. Second, results from CI test 
may not be reliable for high order CI tests when the size of the conditioning set 
is large. As previously described the χ2 statistics depends on P(x; y; z), P(y; z), 
and P(x | z) where x, y, and z are respectively different value assignments to 
the sets of variables X, Y, and Z. If there are many variables in the conditioning 
set Z, there may be very few examples in the data set that satisfy a particular 
value assignment z, and P(x | z) may be inaccurate if there is noise in the 
examples. Similar issues may occur for P(x; y; z) and P(y; z). Hence, for 
algorithms that require high order CI tests, the results may be inaccurate. Third, 
because a network structure is constructed in a step by step manner, the 
construction algorithm may be unstable in the sense that an earlier mistake 
during construction is consequential.  
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1.6 Structure Learning: Search and score methods 
The algorithms based on a scoring function attempt to find a graph that 
maximizes the selected score, which evaluates how well a given network 
matches the data.   
Different learning algorithms can be obtained depending on the definitions of 
the scoring function and on the search procedure used.  
Table 1.1 reports some important definitions, useful in the settling of the scores.  
 
Table 1.1. Definitions. 
i
r
 
number of states of the variable Xi 
ikx  k-th value of Xi 
i
q
 
number of possible configurations of the 
parent set of Xi  
ijw  j-th configuration of pa(Xi) (1<j<qi) 
ijkN  
number of instances in the data D where 
the variable Xi takes its k-th value xik and 
the variables in pa(Xi) take their j-th 
configuration wij 
∑
=
=
i
r
k
ijkij NN
1
 
number of instances in the data D where 
the variables in pa(Xi) take their j-th 
configuration wij 
∑
=
=
iq
j
ijkik NN
1
 
number of instances in the data D where 
the variable Xi takes its k-th value xik 
N
 
total number of instances in the data D 
{ } ni
iG
,....,1== θθ
 
parameters of a BN B with underlying the 
graph G 
{ }
iiji qi ,....,1== θθ
 
parameters concerning only the variable 
Xi in B 
{ } iijkij rk ,....,1== θθ
 
parameters for variable Xi given that its 
parents take their j-th configuration 
 
 
1.6.1 The scores 
Scoring functions are commonly classified into two main categories: 
- Bayesian scoring functions; 
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- Information-theoretic scoring functions. 
 
1.6.1.1 Bayesian scoring functions 
The Bayesian scoring functions compute the posterior probability distribution, 
starting from a prior probability distribution on the possible networks, 
conditioned to data D. The best network is the one that maximizes the posterior 
probability. As it is easier to work in the logarithmic space, the scoring functions 
use the value log(P(B, D)) instead of P(B, D). 
 
BD score 
Heckerman, Geiger and Chickering proposed the Bayesian Dirichlet (BD) Score 
by making different assumptions on P(B, D) [7, 22]. 
Assumption 1: multinomial sample. All variables are discrete and follow a 
multinomial distribution.  
Assumption 2: Dirichlet. All network parameters have a Dirichlet distribution. 
Given a directed acyclic graph G such that P(G)>0 then θij is Dirichlet for all θij in 
θG. 
Assumption 3: parameter independence. The parameters associated with each 
variable are independent (global parameter independence) and the parameters 
associated with each instance of the parents of a variable are independent 
(local parameter independence). This means that the parameters of a node can 
be learned regardless of the parameters of the other nodes.  
Assumption 4: parameter modularity. The probability density functions of the 
parameters associated with a node are identical in two distinct networks if a 
node has the same parents in both networks. Therefore, the local parameters 
for a node, given the same set of parents, have to be deduced once. 
Assumption 5: complete data. The database is complete, namely no missing 
data are allowed.  
Under the above assumptions, the network score is: 
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where p(B) is the prior distribution of B and Γ is the gamma distribution.  
In logarithmic scale, the score becomes:  
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The crucial point is the definition of all hyperparameters N’ijk for all i, j and k. 
Unfortunately, as Heckerman et al. recognized, specifying all N’ijk is formidable, 
to say the least. This makes the BD score unusable in practice. However, there 
are some particular cases of the BD score that are useful. 
 
K2 score 
The K2 score is a particular case of the BD score, obtained with the 
uninformative assignment N’ijk = 1 (corresponding to zero pseudo-counts) [22]: 
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BDe scoring function 
Heckerman, Geiger and Chickering turn around the problem of hyperparameter 
specification by considering one additional assumption [7].  
Two directed acyclic graphs are equivalent if they can encode the same joint 
probability distributions. Given a Bayesian network B, data D can be seen as a 
multinomial sample of the joint space T with parameters θD. The additional 
assumption (number 6) is the likelihood equivalence: given two directed acyclic 
graphs, G and G’, such that P(G)>0 and P(G’)>0, if G and G are equivalent then 
ρ(θD|G)=ρ(θD|G’). 
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Suppose that ρ(θD|G) is Dirichlet with equivalent sample size N’ for some 
complete directed acyclic graph G in T. Then, for any Bayesian network B in T, 
Assumptions 1 through 6 imply: 
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where N’ijk=N’ p(Xi=xik, pa(Xi)=wij│G). 
The equivalent sample size N’ expresses the strength of our belief in the prior 
distribution. 
 
BDeu scoring function 
Buntine proposed a particular case of BDe score, which appears when 
P(Xi=xik,pa(Xi)=wij│G)=1/riqi, that is, the prior network assigns a uniform 
probability to each configuration of (Xi) U pa(Xi) given the complete DAG G [23]. 
The resulting score is called BDeu (“u” for uniform joint distribution) and it is 
expressed as follows: 
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This score depends only on one parameter, the equivalent sample size N’. 
Since there are no generally accepted rule to determine the hyperparameters 
N’x1…..xn, there is no particular good candidate for N’. In practice, the BDeu 
score is very sensitive with respect to the equivalent sample size N’ and so, 
several values are attempted. 
 
1.6.1.2 Information-theoretic scoring functions 
The information-theoretic scoring functions are based on the compression. In 
this context, the score of a Bayesian Network B is related to the compression 
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that can be achieved over the data with an optimal code induced by B. The 
limits to possible data compression are established by the Shannon’s source 
coding theorem (or noiseless coding theorem). The Shannon source coding 
theorem affirms that: as the number of instances of an independent and 
identically distributed data tends to infinity, no compression of the data is 
possible into a shorter message length than the total Shannon entropy, without 
losing information. 
In practice, given data D, one can score a Bayesian network B by the size of an 
optimal code, induced by the distribution B, when encoding D. This value is the 
information content of D by B, expressed as: 
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The Gibb’s inequality justifies the choice of parameters θijk that minimizes 
L(D|B). Gibb’s inequality lemma can be expressed as follows. Let P(x) and Q(x) 
be two probability distributions over the same domain, then: 
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From the previous inequality, when fixing the DAG structure of a Bayesian 
network B, L(D|B) is minimized when 
ij
ijk
N
N
ijk =θ
. 
Clearly, L(D|B) is minimal when the likelihood PB(D) of D given B is maximal, 
which means that the BN that induces a code that compresses D the most is 
precisely the Bayesian network that maximizes the probability of observing D. 
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LL scoring function 
By applying a logarithm to the likelihood of D given B, is obtained 
log(P(B(D))=−L(D|B) that is commonly called the log-likelihood of D given B. It 
can be noticed that maximizing the loglikelihood is equivalent to minimizing the 
information content of D by B. This leads to defining the log-likelihood (LL) 
score in the following way [24]: 
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The LL score tends to favor complete network structures and it does not provide 
an useful representation of the independence assumptions of the learned 
network. This phenomenon of overfitting is usually avoided in two different 
ways: by limiting the number of parents per network variable or by using some 
penalization factor over the LL score. The second approach is of great interest 
and it will be discussed in the following. 
 
MDL scoring function 
The minimum description length (MDL) scoring function [25] is an Occam’s 
razor approach to fitting, preferring simple Bayesian networks over complex 
ones, and it is defined as: 
 
BNBDLLBDMDL )log(
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where: 
∑
=
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n
i
ii qrB
1
)1(
 denotes the network complexity [26], that is, the number of 
parameters in θ for the network B. The first term of the score measures how 
many bits are needed to describe the data based on the probability distribution 
PB, whereas the second term represents the length of describing the network B, 
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that is, the number of bits needed to encode B, where 1/2 log(N) bits are used 
for each parameter in θ. 
 
AIC and BIC scoring functions 
The measure of the quality of a Bayesian Network can be computed in several 
different ways. This leads to a generalization of the MDL scoring function given 
by: 
 
BNfBDLLBDMDL )()()( −=
            (1.12) 
 
where f(N) is a non-negative penalization function.  
• If f(N)=1, the Akaike Information Criterion (AIC) scoring function is obtained 
[27], expressed as:  
 
BBDLLBDAIC −= )()(
        (1.13) 
 
• If f(N)=1/2 log(N), we have the Bayesian Information Criterion (BIC) score 
based on Schwarz Information Criterion [28], which coincides with the MDL 
score.  
 
1.6.1.3 Decomposability  
For efficiency purposes, a scoring function needs to have the property of 
decomposability. A scoring function is decomposable if the score assigned to 
each network decompose over the network structure in such a way that it can 
be expressed as a product of local scores that depends only on each node and 
its parents, that is, scores of the following form: 
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1.6.2 Search algorithms 
It has been shown that the search for optimal BN structures is a NP-Hard 
problem [7]. A problem is NP-hard when the complexity class of decision 
problems are intrinsically harder than those that can be solved by a 
nondeterministic Turing machine in polynomial time. This result has been used 
to justify the use of large number of heuristic strategies for the exposed 
problem.  
Most of the search algorithms to learn the Bayesian Networks through scores 
are in the Local Search Algorithm family (LSA). A local search algorithm is a 
search algorithm which uses just the current state instead of the whole 
optimization path. The main advantage of LSAs is that they can find a solution 
in incredibly large spaces and they need a constant memory requirement. 
Unfortunately, this kind of algorithm does not guarantee the requirement of 
optimality and sometimes only a local maximum is reached. Even with this 
drawback, the LSAs are an irreplaceable instrument for optimization problems, 
especially those characterized by a large dimension of the search space. 
The most usual approach to perform the search of BN model is to explore the 
space of DAGs, but the search of the best BN can be performed also in different 
spaces. For example, using the BDe the search can be executed in the space 
of equivalent classes, that is classes characterized by the same set of 
conditional independencies. Recent results also suggest to perform the search 
in the space of skeletons or of undirected graphs. Other authors have proposed 
a search in the space of orders of the variables (nodes) of the problem. The 
motivation for the birth of this approach is that several structure learning 
algorithms need the ordered variables. 
In what follows, the attention is focused on methods performing the search in 
the space of graphs. In this space, many of the search methods, including those 
described, use the above described decomposability property of the score 
metric. Given a decomposable metric, two network structures that differ just by 
the addition or deletion of an edge pointing to the node Xi are compared by the 
term s(Xi|pa(Xi)) for both structures. The use of the decomposition permits to 
save computational resources while comparing two structures. 
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Several search heuristic strategies to find a near-optimal Bayesian network 
models have been proposed in the literature and they can be divided into 
deterministic heuristic and stochastic heuristic. 
 
1.6.2.1. Deterministic heuristic search strategies 
Some examples of deterministic heuristic search strategies are hill climbing o 
greedy search [22], iterated hill climbing [29], tabu search [24] and branch and 
bound [30]. 
 
Greedy search 
The greedy search starts at a specific point: an initial structure in the structure 
space. After, the algorithm considers all neighbors of the current point, and 
moves to the neighbor that has the highest score (direction of the greatest 
positive change). The neighbors are the structures that can be generated from 
the current structure by adding, deleting or reversing a single arc, subject to the 
acyclicity constraint. If no neighbors have higher score than the current point, 
the algorithm stops. The main advantage of this approach is its simplicity. The 
drawback of this algorithm is that it picks the choice that myopically looks best. 
Even if very little memory is required, there is a very high probability to 
prematurely converge in local optima or in plateau. The application of random 
restarts allows to solve this problem [29]. The search is run until an optimum is 
reached. Then a new initial state is randomly chosen and the algorithm is run 
again. After n iterations a good solution is sought, with a satisfying compromise 
between the computational complexity and the optimality. 
 
Tabu Search Heuristic  
The local search algorithm used is a simple greedy hill-climbing algorithm 
augmented with a Tabu list [24]. In its simplest form, a Tabu list contains 
recently visited solutions (less than a defined number of moves ago). Instead of 
applying the best local change, the algorithm selects the best local change 
resulting in a solution not existing in the Tabu list. The local search procedure 
terminates when a certain number of local changes fail to present an 
improvement over the current solution. 
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The local moves done by the search algorithm select one of the candidate 
edges at random and alter its probability. The probability altering is 
accomplished by sampling a new value from the edge probability distribution. 
Edge distribution follows a softmax distribution parameterized by the 
temperature T=1/β. Parameterizing the distribution by the temperature makes it 
more discriminating as the temperature is lowered. This parameterization 
assures that the lower the temperature, the nearer the probabilities are to 0 or 
1. 
If u is a random number sampled from a zero-mean Gaussian distribution, the 
edge probability can be calculated as follows: 
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1.6.2.2. Stochastic heuristic search strategies 
Some examples of stochastic heuristic search strategies are genetic algorithms 
[31], simulated annealing [29], variable neighborhood search [32], evolutionary 
programming [33], estimation of distributions algorithms (EDA) [34], Markov 
chain Monte Carlo [35], and ant colonies [36].   
 
Simulated Annealing 
In the simulated annealing algorithm (SA) “bad” actions are occasionally chosen 
to avoid becoming trapped at a local maximum. As its name implies, the 
simulated annealing exploits an analogy between the way in which a metal 
cools and freezes into a minimum energy crystalline structure (the annealing 
process) and the search for an optimum in quite different type of structures  [29, 
37]. 
The algorithm employs a random search which not only accepts changes that 
optimize the objective function f, but also some changes that do not increase it. 
The latter are accepted with a probability that follows the Boltzmann distribution: 
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where s represents the current state, c the new state and T a control parameter, 
which by analogy with the original application is known as the system 
temperature irrespective of the objective function involved. When searching for 
the best BN, the new state is reached by performing an action: addition, 
deletion or reversal of an edge between two nodes. Practically, the system is 
initialized to some initial temperature T0. Then an eligible solution e is picked at 
random, and the Boltzmann distribution is evaluated. If the value of p is greater 
than 1 then the new solution is accepted, otherwise the solution is accepted 
with a probability p. The selection and evaluation processes are iterated L times 
or until M changes are obtained. If no changes occur in L iterations, then the 
algorithm stops. Otherwise the temperature is lowered and the search process 
continues. The search process is stopped if the temperature has been lowered 
more than N times. Thus, this algorithm is controlled by the parameters that we 
must to provide: T0, L, M, N. The simulated annealing can be very effective in 
domains with many local optima. The weakness of the method is the selection 
of a good cooling schedule that guarantee the temperature T is lowered “slowly 
enough”. To solve this problem a calibration step can be used. 
 
Genetic Algorithms 
Genetic Algorithms (GAs) are search algorithms based on the mechanics of 
natural selection and natural genetics formulated by Darwin [38].  
In GAs the search space is explored by examining a small collection of 
candidate solutions, called population of individuals. The purpose of GAs is to 
find the individual from the search space with the best “genetic material”, that is, 
a candidate argument maximizing the value of the objective function (measure 
of the quality of an individual) [31, 39].  
A genetic algorithm iterates some basic steps every generation. First, the initial 
population is chosen, and the quality of each individual is measured. Next, at 
every iteration, parents are selected from the current population and they 
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produce children. All newly created individuals undergo to mutation with 
probability near zero. Then, individuals are evaluated by an objective function. 
Some individuals die and they are removed from the population according to a 
specified selection criterion, so that the population size is constant. One 
iteration of the above steps is referred to as a generation. The operators which 
define the child production process and the mutation process are called the 
crossover operator and the mutation operator, respectively. Both operators are 
applied with different probabilities named the crossover probability and the 
mutation probability. Mutation and crossover play different roles in the GA. 
Mutation is needed to explore new states and helps the algorithm to avoid local 
optima. Crossover should increase the average quality of the population. By 
choosing adequate crossover and mutation operators as well as an appropriate 
reduction mechanism, the probability that the GA results in a near-optimal 
solution in a reasonable number of iterations increases. 
Generally, in order to represent the individual-chromosome using a string, a n-
nodes BN is first represented as a connectivity matrix C of dimension nXn, 
where each element cij =1 if if j is a parent of i, 0 otherwise. 
 
 
1.7 The DEAL package for structural learning 
DEAL is a software package coded in the R environment which includes several 
methods for analyzing data using Bayesian Networks [5]. The package can be 
downloaded from the Comprehensive R Archive Network (CRAN) (http://cran.R-
project.org/) and may be used freely for non-commercial purposes. 
In DEAL a BDe (Bayesian with Dirichlet prior and Equivalence) score extended 
to Conditional Gaussian-Bayesian Networks (CG-BNs) is implemented to 
evaluate how well a given network matches the data and a Greedy Search 
algorithm with random restart is used as the search engine optimizing the BDe 
score.  
 
 
Meloni Antonella                                                                                               Part I 
 
36 
          2 BN structure learning: 
design of a new approach 
 
2.1 Introduction  
The metric implemented in DEAL described in the previous chapter often 
converges to a complete network, overestimating the number of connections 
among variables (figure 2.1).  
So, the main goal of this thesis is the development of a new method for BNs 
structure learning which uses the same basis approach of DEAL but applies a 
strategy to prevent the inference of too many connections. This constrained 
approach is coded on the top of the package DEAL and comprises 3 steps, 
described in the sequel [8, 9, 10]. 
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Figure 2.1. Simple example of the malfunction of the algorithm implemented in 
DEAL. Top: true network structure. Bottom: network inferred by using DEAL. 
 
 
2.2 First step: computation of the mutual information matrix  
The first step of the developed algorithm is the computation of the mutual 
information matrix (MIM). The MIM is a square matrix whose i,j element is the 
mutual information (MI) between Xi and Xj.  
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2.2.1 Mutual information 
Mutual information measures the general dependence of random variables 
without making any assumptions about the nature of their underlying 
relationships [40]. Assume that the variable Xi has M possible states xi1,….,xiM, 
each with its corresponding probability p(xim). The probabilities of the states are 
easily computed by counting their occurrences and dividing by the total number 
of occurrences. The average amount of information gained from a 
measurement that specifies one particular state xim is given by the entropy H(Xi) 
of the variable, defined by Shannon [41] as: 
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The Shannon entropy of Xi becomes zero if the outcome of a measurement of 
Xi is completely determined to be xir, thus if p(xir)=1 and p(xim)=0 for all m≠r, 
whereas the entropy becomes maximal if all probabilities are equal. The joint 
entropy H(Xi, Xj) of two discrete variables Xi and Xj  is defined analogously as: 
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Here p(xim, xjl) denotes the joint probability that Xi is in state xim and Xj is in state 
xjl, calculated from a multivariate histogram. The number of possible states M 
and L may be different. This leads to the relation: 
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which fulfils equality only in the case of statistical independence of Xi and Xj. 
The mutual information MI(Xi, Xj) between the variables Xi and Xj is then defined 
as [41, 42]: 
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MI is equal to zero if Xi and Xj are statistically independent and increases the 
less statistically independent Xi and Xj are.  
 
2.2.2 Data preparation: discretization of continuous variables 
The equations 2.1 and 2.2 require discrete variables, so the algorithm includes 
an eventual early stage that comes first the MI calculation: the discretization of 
the continuous variables present in the database. The equal frequency 
discretization method is implemented, very attractive because of its simplicity 
[43]. It divides a continuous variable into k=√M bins, where M is the number of 
instances. Each bin contains the same number (possibly duplicated) of adjacent 
values.  
 
 
2.3 Second step: MIM Binarization 
Since MI is always non-negative, its evaluation from random samples gives a 
positive value even for variables that are, in fact, mutually independent. 
Moreover, entropy estimation based on relative frequencies has several 
sources of error, such as finite number of observations [44]. The binarization 
process cannot be done by assigning 0 at all the null elements in the matrix and 
1 at the other ones, but more complex methods are required. So, more complex 
approaches finding out a binary matrix starting from the MIM are implemented 
[9] [10] [8].  
 
 2.3.1 Threshold of MI 
The elements of the MIM larger than the threshold I0 are transformed to state 1 
and the elements smaller than I0 are transformed to state 0.  
The MIM is symmetric and the upper triangle is extracted. A vector constituted 
by the selected elements is created and the percentiles of its distribution are 
calculated. The percentiles are the 100-quantiles, namely the quantiles 
expressed as percentage. The quantiles are calculated by using the algorithm 
number 8 discussed in Hyndman and Fan [45]. The resulting quantile estimates 
are approximately median-unbiased regardless of the distribution of data whose 
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sample quantiles are wanted. Each calculated percentile (10th, 15th, 20th, 25th, 
30th, 35th, 40th, 45th, 50th, 55th and 60th) can be used as threshold.  
 
2.3.2 MRMR method 
The MRMR method allows to select variables in a stepwise mode so that each 
new variable selected has the highest individual MI with the output (maximum 
relevance) and the lowest possible average MI with the preselected variables 
(minimum redundancy) [46, 47]. In a supervised learning task, the output is 
denoted by Y and V represents the set of input variables. The greedy search 
starts by selecting the variable Xi that has the highest MI to the target Y. After it 
selects the variable Xj that has a high information MI(Xj, Y) to the target and at 
the same time a low information MI(Xj, Xi) to the previously selected variable. In 
the following steps, given a set S of selected variables, the method updates S 
by choosing the variable Xj that maximizes the score:   
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This selection procedure is repeated considering at every turn a different 
variable as target. For each pair (Xi, Xj), MRMR returns two (not necessarily 
equal) scores si and sj according to (2.5). The score of the pair (Xi, Xj) is then 
computed by taking the maximum between si and sj. A square and symmetric 
matrix whose i, j element is the score of the pair (Xi, Xj) is defined. The matrix is 
binarized assigning 0 at all the null elements in the matrix and 1 at the 
remaining ones.  
 
2.3.3 CLR method 
The CLR (Context Likelihood of Relatedness) algorithm transforms the MIM 
matrix into a matrix of scores that take into account the empirical distribution of 
the MI values [48]. The rational is that the most probable interactions are those 
whose scores stand significantly above the background distribution of scores. 
For each couple of variables Xi and Xj, the score is calculated as: 
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µi and σi are, respectively, the mean and the standard deviation of the empirical 
distribution of the mutual information values MI(Xi,Xk), with k = 1, . . . , n. The 
score matrix is subsequently binarized by assigning 0 at all the null elements in 
the matrix and 1 at the remaining ones.  
 
2.3.4 ARACNE method 
ARACNE stands for algorithm for the reconstruction of accurate cellular 
networks. It uses a well-known information theoretic property, the data 
processing inequality (DPI), in order to eliminate the majority of the inferred 
indirect interactions [49]. The DPI [40]  states that if two variables Xi and Xz 
interact only through a third variable, Xj, then: 
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A weight equal to their mutual information is assigned to each pair of nodes. 
Then, the algorithm examines each variables triplet and removes the arc with 
the smallest value (i.e. assigns value 0 in the matrix). A square and symmetric 
matrix, containing all MIs for pairs of variables considered directly interacting 
and 0 otherwise, is computed. The matrix is binarized by assigning 0 at all the 
null elements and 1 at the remaining ones.  
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2.4 Step 3: Search constrained 
Finally, the binary MIM is exploited as a pre-conditioning step for the greedy 
search procedure. It represents a sort of skeleton for the BN (graph not 
oriented), establishing which network structures are acceptable. So, it allows to 
reduce the size of the search space. If the element i,j in the skeleton matrix is 
equal to 0, an arc between the two correspondent variables Xi and Xj will be not 
allowed in the greedy search algorithm. Consequently, each network which 
contains any of these arcs is disregarded. Figure 2.2 schematizes the 
constrained search procedure. 
The general name “search and score (S&S)+MI preconditioning” is attributed to 
the developed approach. So, depending on the method used to binarize the 
MIM, 4 different algorithms can be identified: S&S + threshold, S&S+ MRMR, 
S&S+ CLR and S&S+ ARACNE. 
 
 
Figure 2.2. Schematic example of the working of the developed algorithm. In a 
search constrained by S, G2 can’t be considered because the arc from B to E. 
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3 Performance analysis 
 
In this section the procedure developed to evaluate the quality of the networks 
learned is described.  
 
 
3.1 Networks 
The proposed metrics were numerically investigated by means of three different 
discrete datasets. The first two of them, namely ASIA and CANCER, are two 
medical datasets that have been often used in the machine learning field. The 
ASIA network, introduced by Lauritzen and Spiegelhalter [50], is a small 
network constituted by 8 discrete variables and 8 arcs (Figure 3.1A). The 
CANCER network includes 5 discrete variables and 5 arcs (Figure 3.1B) [12]. 
The third dataset is a synthetic dataset used as a test case in a R package 
centered on BNs: the bnlearn package [51]. The network comprises 6 discrete 
variables and 5 arcs and here it is called BN (Figure 3.1C). 
In order to evaluate the applicability of the developed approach in the 
continuous case, a synthetic dataset with 7 continuous variables was introduced 
[51]. All the variables are normal, so the network has been named GAUSSIAN 
(Figure 3.1D).  
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Figure 3.1. Network used in the performance analysis procedure: ASIA (A), 
CANCER (B), BN (C), and GAUSSIAN (D). 
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3.2 Experimental procedure 
Each network was used to generate several databases by means of 
probabilistic logic sampling method [52]. The probabilistic logic sampling 
method should be credited as the first algorithm applying stochastic sampling to 
belief updating in Bayesian networks. Essentially, it is based on forward (i.e., 
according to the weak ordering implied by the directed graph) generation of 
instantiations of nodes guided by their probability. If a generated instantiation of 
an evidence node is different from its observed value, then the entire sample is 
discarded. This makes the algorithm very inefficient if the prior probability of 
evidence is low. The algorithm is very efficient in cases when no evidence is 
observed or the evidence is very likely.  
The sample sizes considered were N = 1000, 5000 and 10000 for ASIA, BN 
and GAUSSIAN networks and N = 1000, 2500 and 5000 for CANCER network, 
being smaller. The databases were used as input for the algorithms (DEAL and 
the developed metric using different binarization methods) implemented in R. 
Figure 3.2 summarizes the whole process of performance analysis.  
 
 
Figure 3.2. Scheme of the performance analysis. 
 
 
3.3 Measures of performance 
Different criteria were selected to gauge the quality of the reconstructed 
structure. They are described in the sequel. 
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• Number of correct arcs or true positive (TP): number of arcs in the inferred 
network that are present also in the underlying true network. 
• Number of extra arcs or false positive (FP): number of arcs present in the 
inferred network that are absent in the underlying true network. 
• True negative (TN): number of arcs absent in the inferred network that are 
absent even in the underlying true network. 
• Number of missing arcs or false negative (FN): number of arcs absent in the 
inferred network but present in the underlying true network. 
The decision made by the algorithm can be summarized by a confusion matrix 
(see Table 3.1). 
 
Table 3.1. Confusion Matrix. 
  TRUE NETWORK 
 Arc Present Absent 
Present TP FP INFERRED 
NETWORK Absent FN TN 
 
• Accuracy (a): proportion of true results (both true positives and true 
negatives). An accuracy of 100% means that the measured values are exactly 
the same as the given values.  
 
TNFNFPTP
TNTP
a
+++
+
=
         (3.1) 
 
• Precision (p): fraction of real edges (present in the real network) among the 
ones inferred by the algorithm. 
 
FPTP
TPp
+
=
    (3.2) 
 
• Recall (r) or true positive rate or sensitivity: fraction of real edges that are 
correctly inferred. 
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FNTP
TP
r
+
=
    (3.3) 
 
• F-score: harmonic average of precision and recall [53]. 
 
rp
rpFscore
+
=
**2
      (3.4) 
 
• Jaccard’s coefficient (J): measure of the similarity between 2 structure 
networks. 
 
FNFPTP
TPJ
++
=
         (3.5) 
 
The running time of each algorithm was also annotated. The running times were 
normalized by dividing by the corresponding running time of DEAL on the same 
dataset with the same sample size. 
 
 
3.4 Applicability with real Databases 
 
3.4.1 Datasets 
In order to evaluate the applicability of the developed approach in real-world 
problems, it  was applied  even with two real databases.  
The first dataset was a little extract of the MIOT (Myocardial Iron Overload in 
Thalassemia) database, provided by the Magnetic Resonance Imaging 
Laboratory of the Fondazione G.Monasterio CNR-Regione Toscana in Pisa. 
The MIOT database is a clinical database easily accessible via a web interface. 
It is configured to collect and share the data of the thalassemic patients enrolled 
in the MIOT Network. The MIOT network is an Italian network constituted by 
thalassemia and magnetic resonance imaging (MRI) centers. Thalassemia 
centers are responsible for patient recruitment and collection of anamnestic and 
clinical data. MRI centers have been equipped with a standardized acquisition 
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technique and an affordable workstation for image analysis. They are able to 
perform feasible and reproducible heart and liver iron overload assessments for 
a consistent number of thalassemia patients in a robust manner [54, 55]. The 
considered extract comprises 7 binary (yes or no) variables: 
- Card_Dis: presence of a cardiac disease; 
- AntiHCV: presence of the antibody for the Hepatitis C infection; 
- Red_LVEF: reduced left ventricular ejection fraction (LV EF), representing the 
fraction of blood pumped out of the left ventricle with each heart beat; 
- Pat_HeartT2*: pathological (<20 ms) global heart T2* (parameter measured by 
the MRI, inversely correlated to the iron concentration); 
- Pat_LiverT2*: pathological liver T2*; 
- Aug_Ferr: augmented (value higher than the normal cut-off) serum ferritin 
levels; 
- Fibrosis: presence of cardiac fibrosis, detected by cardiac MRI. 
The number of cases (patients)  was 476. 
The second dataset was collected by a single observer of the Fondazione 
G.Monasterio CNR-Regione Toscana in Pisa. The dataset comprises 9 binary 
variables. One variable (disease) indicates the presence of a cardiac disease 
and the other variables represent the well-known cardiac risk factors: heredity, 
gender, age, smoking, high cholesterol, tryglicerides, high blood pressure, 
obesity. 
 
3.4.2 Inferred Networks Estimation 
For real databases a reference BN is obviously not present, so in order to 
assess somehow the quality of the constructed networks, two different ways, 
alternative to the previously described procedure, were used. 
Firstly, the constructed networks were shown to an expert operator who 
expressed his personal opinion.  
Secondly, a classical statistic analysis was performed to test if two categorical 
variables were associated. SPSS version 13.0 statistical package was used. 
Being the variables all categorical, a chi-square test was used. The 
relationships obtained after the test execution were compared with the arcs 
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present in the inferred networks. Obviously, in this case no consideration was 
made about the direction of one arc. 
 
3.4.2.1 The Chi-square 
The chi-square [56] provides a quantitative measure of the relationship between 
two categorical variables, first, by determining what the distribution of 
observations (frequencies) would look like if no relationship exists and, second, 
by quantifying the extent to which the observed distribution differs from that 
determined in the first step. Clearly, when the data indicate that no relationship 
exists between the variables, the values of observed and expected frequencies 
must be identical. Also, the greater the relationship, the greater the difference 
between the observed and expected frequencies. The chi-square statistic (Χ2) 
measures the difference between the expected and observed frequencies and 
is thus a quantitative measure of this relationship. Chi-square is defined in the 
following manner: 
 
∑
−
i i
ii
E
EO 2)(
      (3.6) 
 
where Oi is the observed frequency in a cell and Ei is the expected frequency in 
a cell. As is readily seen, when Ei=Oi, the chi-square value for that cell is zero. 
In short, when no relationship exists between the variables, chi-square equals 
zero. The greater the relationship, the greater the value of chi-square. Finally, it 
can be noticed also that chi-square is always positive and that it provides no 
information about the direction of the relationship. As with other test statistics, 
the obtained value is compared with the critical value to determine whether to 
reject or retain the null hypothesis. For a chi-square test, the null hypothesis is 
that the two sets of frequencies (i.e., observed and expected) are equal. The 
alternative hypothesis is that they are unequal. 
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4 The new algorithm: results 
 
4.1 Calculation of the best threshold 
First, the dependence of the algorithm S&S + threshold results on the threshold 
values was investigated. The three discrete databases were used for this 
purpose. 
For the networks, the algorithm ran considering different threshold values for 
each sample size. Figures 4.1 and 4.2 show the correspondent F-scores 
obtained. Regardless of the sample size, by increasing the threshold values up 
the 50th percentile, the performances of the algorithm tended to improve or, 
sometimes, to hold steady. For higher threshold values the F-score decreased 
again. So, the best threshold was represented by the 50th percentile for all the 
networks. Moreover, by increasing the sample size, a best score was obtained. 
As can been seen in figure 4.2, by using the optimal threshold and a sample 
size of at least 2500, the true structure of the CANCER network  was inferred. 
 
 
Figure 4.1. F-scores of the method S&S+threshold by varying the MI thresholds 
for the ASIA network. For all sample size, the 5th, 10th, 15th and the 20th 
percentiles were the same. 
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Figure 4.2. F-scores of the method S&S+threshold by varying the MI thresholds 
for the CANCER network. For all sample size, the 5th, 10th and the 15th 
percentiles were the same. 
 
 
 
Figure 4.3. F-scores of the method S&S+threshold by varying the MI thresholds 
for the BN network. For all sample size, the 5th, 10th 15th, 20th and the 25th 
percentiles were the same. 
 
 
4.2 Comparison among the algorithms 
Results of the learned network using the metric implemented in DEAL and the 
algorithms implemented, namely S&S + threshold (with the use of the best 
threshold), S&S+ MRMR, S&S+ CLR and S&S+ ARACNE are shown in Table 
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4.1 and in figure 4.4 for ASIA network, in Table 4.2 and in figure 4.5 for 
CANCER network, in Table 4.3 and in figure 4.6 for BN network.  
Irrespective of the method used to binarize the MIM, the implemented 
constrained approach always improved the overall performance of the metric 
implemented in DEAL.  From all the above mentioned tables it is easy to notice 
that, as previously pointed out, the main problem of the DEAL algorithm is the 
low precision, due to the high number of false positives. The application of our 
strategy allowed clearing this hurdle.  
For the ASIA network, the application of the ARACNE method to binarize the 
MIM gave better results than the other approaches. It was equaled by the CLR 
method for a sample of at least 5000. For this DB size, the use of these 
methods in the skeleton definition allowed the reconstruction of the true 
structure of the network. The lowest performance was obtained when the 
threshold was used to binarize the MIM. Its main problem was the low precision. 
In fact, the recall was 1 for all the approaches, indicating that all the real edges 
were correctly inferred. 
For the CANCER network, the performance of the developed approach was 
always the same, without any difference depending on the binarization method. 
The developed approach allowed the finding of the true network for a sample 
size larger than 2500.  
For the BN network, the application of the ARACNE method to binarize the MIM 
gave the best results and allowed the construction of the true network, 
regardless to the sample size. All the other approaches gave exactly the same 
results. The critical point was again the presence of FP.  
The general trend for all the algorithms was that the networks learned from 
them were more and more accurate as the size of the datasets gradually 
enlarged.  
Finally, our algorithms had always a lower running time than DEAL.  
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Table 4.1. Experimental results of all the algorithms on ASIA network by varying 
the sample size. 
Sample size 
                                 Algorithm 
 Performance 1000 5000 10000 
Correct arcs 
or True 
Positive 
DEAL 
S&S+ threshold 
S&S+ MRMR 
S&S+ ARACNE 
S&S+ CLR 
4 
8 
8 
8 
8 
5 
8 
8 
8 
8 
7 
8 
8 
8 
8 
Incorrect 
added arcs or 
False Positive 
DEAL 
S&S+ threshold 
S&S+ MRMR 
S&S+ ARACNE 
S&S+ CLR 
18 
9 
4 
1 
1 
18 
9 
2 
0 
1 
15 
8 
1 
0 
0 
True Negative 
DEAL 
S&S+ threshold 
S&S+ MRMR 
S&S+ ARACNE 
S&S+ CLR 
38 
47 
52 
55 
55 
38 
47 
54 
56 
55 
41 
48 
55 
56 
56 
Missing arcs  
or False 
Negative 
DEAL 
S&S+ threshold 
S&S+ MRMR 
S&S+ ARACNE 
S&S+ CLR 
4 
0 
0 
0 
0 
3 
0 
0 
0 
0 
1 
0 
0 
0 
0 
Accuracy 
DEAL 
S&S+ threshold 
S&S+ MRMR 
S&S+ ARACNE 
S&S+ CLR 
0.66 
0.86 
0.94 
0.98 
0.98 
0.67 
0.86 
0.97 
1 
0.98 
0.75 
0.88 
0.98 
1 
1 
Precision 
DEAL 
S&S+ threshold 
S&S+ MRMR 
S&S+ ARACNE 
S&S+ CLR 
0.18 
0.47 
0.67 
0.89 
0.89 
0.22 
0.47 
0.80 
1 
0.89 
0.32 
0.50 
0.89 
1 
1 
Recall 
DEAL 
S&S+ threshold 
S&S+ MRMR 
S&S+ ARACNE 
S&S+ CLR 
0.50 
1 
1 
1 
1 
0.62 
1 
1 
1 
1 
0.87 
1 
1 
1 
1 
Normalized  
running time  
DEAL 
S&S+ threshold 
S&S+ MRMR 
S&S+ ARACNE 
S&S+ CLR 
1 
0.63 
0.43 
0.30 
0.37 
1 
0.59 
0.42 
0.29 
0.32 
1 
0.61 
0.37 
0.29 
0.34 
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Figure 4.4. F-score and Jaccard’s coefficient for all the algorithms on ASIA 
network by varying the sample size. 
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Table 4.2. Experimental results of the three algorithms on CANCER network by 
varying the sample size. 
Sample size 
                                       Algorithm  
Performance  1000 2500 5000 
Correct arcs 
or True 
Positive 
DEAL 
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
4 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
Incorrect 
added arcs or 
False Positive 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
3 
1 
1 
1 
1 
1 
0 
0 
0 
0 
1 
0 
0 
0 
0 
True Negative 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
17 
19 
19 
19 
19 
19 
20 
20 
20 
20 
19 
20 
20 
20 
20 
Missing arcs  
or False 
Negative 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Accuracy 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
0.84 
0.96 
0.96 
0.96 
0.96 
0.96 
1 
1 
1 
1 
0.96 
1 
1 
1 
1 
Precision 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
0.57 
0.83 
0.83 
0.83 
0.83 
0.87 
1 
1 
1 
1 
0.87 
1 
1 
1 
1 
Recall 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
0.8 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
Normalized  
running time  
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
1 
0.65 
0.65 
0.6 
0.6 
1 
0.65 
0.65 
0.6 
0.6 
1 
0.65 
0.65 
0.6 
0.6 
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Figure 4.5. F-score and Jaccard’s coefficient for all the algorithms on CANCER 
network by varying the sample size. 
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Table 4.3. Experimental results of the three algorithms on BN network by 
varying the sample size. 
Sample size 
                                        Algorithm  
Performance  1000 5000 10000 
Correct arcs 
or True 
Positive 
DEAL 
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
4 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
Incorrect 
added arcs or 
False Positive 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
8 
3 
3 
0 
3 
4 
2 
2 
0 
2 
3 
1 
1 
0 
1 
True Negative 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
23 
28 
28 
31 
28 
27 
29 
29 
31 
29 
28 
30 
30 
31 
30 
Missing arcs  
or False 
Negative 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Accuracy 
DEAL  
S&S+ threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
0.75 
0.92 
0.92 
1 
0.92 
0.89 
0.94 
0.94 
1 
0.94 
0.92 
0.97 
0.97 
1 
0.97 
Precision 
DEAL  
S&S+ threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
0.33 
0.6 
0.63 
1 
0.63 
0.55 
0.71 
0.71 
1 
0.71 
0.63 
0.83 
0.83 
1 
0.83 
Recall 
DEAL  
S&S+ threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
0.8 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
Normalized  
running time  
DEAL  
S&S+ threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
1 
0.82 
0.73 
0.45 
0.54 
1 
0.83 
0.75 
0.38 
0.46 
1 
0.84 
0.77 
0.5 
0.5 
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Figure 4.6. F-score and Jaccard’s coefficient for all the algorithms on BN 
network by varying the sample size. 
 
 
4.4 Applicability in the continuous case 
The developed approach can be used even for databases with continuous 
variables, discretized before the MI calculation. The results obtained with the 
different algorithms are shown in table 4.4 and in figure 4.7 . 
Even in the continuous case the use of the MI binary matrix as a 
preconditioning for the subsequent greedy search procedure allowed to obtain a 
better network, improving the overall performance of the metric implemented in 
DEAL. The best performance of the developed algorithm was obtained when 
ARACNE was used as binarization strategy. 
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Table 4.4. Experimental results of the algorithms on GAUSSIAN network by 
varying the sample size. 
Sample size                              Algorithm 
Performance 1000 5000 10000 
Correct 
arcs or 
True 
Positive 
DEAL  
S&S+threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
5 
5 
6 
6 
6 
6 
6 
6 
7 
6 
6 
6 
6 
7 
6 
Incorrect 
added arcs 
or False 
Positive 
DEAL  
S&S+threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
6 
6 
5 
4 
5 
6 
5 
4 
3 
3 
5 
3 
3 
3 
3 
True 
Negative 
DEAL  
S&S+ threshold  
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
36 
36 
37 
38 
37 
36 
37 
38 
39 
39 
37 
39 
39 
39 
39 
Missing 
arcs  
or False 
Negative 
DEAL  
S&S+threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
2 
2 
1 
1 
1 
1 
1 
1 
0 
1 
1 
1 
1 
0 
1 
Accuracy 
DEAL  
S&S+threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
0.84 
0.84 
0.88 
0.89 
0.88 
0.86 
0.88 
0.89 
0.94 
0.92 
0.86 
0.92 
0.92 
0.94 
0.92 
Precision 
DEAL  
S&S+threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
0.45 
0.45 
0.54 
0.60 
0.54 
0.50 
0.54 
0.60 
0.70 
0.67 
0.54 
0.67 
0.67 
0.70 
0.67 
Recall 
DEAL  
S&S+threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
0.71 
0.71 
0.86 
0.86 
0.86 
0.86 
0.86 
0.86 
1 
0.86 
0.86 
0.86 
0.86 
1 
0.86 
Normalized  
running 
time  
DEAL  
S&S+threshold 
S&S+ MRMR  
S&S+ ARACNE  
S&S+ CLR 
1 
0.84 
0.74 
0.45 
0.55 
1 
0.86 
0.75 
0.40 
0.55 
1 
0.87 
0.80 
0.50 
0.50 
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Figure 4.7. F-score and Jaccard’s coefficient for all the algorithms on 
GAUSSIAN network by varying the sample size. 
 
 
4.5 Applicability with real Databases 
 
4.5.1 MIOT Database 
Figure 4.8 shows the BN obtained for the MIOT dataset. Eleven arcs were 
inferred: 
1. Fibrosis → Aug_Ferr; 
2. Aug_Ferr → Pat_HeartT2* 
3. Aug_Ferr → Pat_LiverT2* 
4. Aug_Ferr → AntiHCV 
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5. Aug_Ferr → Card_Dis 
6. Pat_LiverT2* → Pat_HeartT2* 
7. Pat_LiverT2* → AntiHCV 
8. Card_Dis → AntiHCV 
9. Pat_HeartT2* → Red_LVEF 
10. Pat_HeartT2* → Card_Dis 
11. Red_LVEF → Card_Dis 
 
 
Figure 4.8. Bayesian Network obtained for the variables in the MIOT dataset. 
 
Only the arc number 1 was considered without any sense by the expert. All the 
arcs expected by the expert (2, 3, 6, 9, 10, 11) on the basis of her experience 
and data available in the literature, were detected by the algorithm. If the 
expected arc are considered as a sort of “true arcs”, a recall =1, given by the 
absence of FN, could be assigned to the algorithm.  
Table 4.5 shows the all the pairs of variables for which the Chi-square Test was 
significant.  
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Table 4.5. Significant relationships obtained with the Chi-square test. 
Pairs Chi square P 
AntiHCV – Card_Dis 13.92 <0.0001 
AntiHCV – Aug_Ferr 36.99 <0.0001 
AntiHCV – T2*feg_pat 29.77 <0.0001 
Card_Dis – Aug_Ferr 5.77 0.016 
Card_Dis – Red_LVEF 13.26 <0.0001 
Card_Dis –  Pat_HeartT2* 14.29 <0.0001 
Aug_Ferr – Pat_LiverT2* 109.95 <0.0001 
Aug_Ferr – Pat_HeartT2* 32.84 <0.0001 
Red_LVEF – Pat_HeartT2* 24.75 <0.0001 
Pat_LiverT2*– Pat_HeartT2* 20.69 <0.0001 
 
Without considering the direction of the arc in the inferred BN and considering 
instead each arc as an indication of a relationship between the 2 variables, a 
good agreement was found between the connections found with our approach 
and the statistical test.  Specifically, if the results of the test are considered to 
be the “true relationships”, among the relationships found out with our approach 
one FN and one FP were identified (figure 4.9).  
 
 
Figure 4.9. Comparison for the MIOT database between the relationships 
represented by an arc in the inferred BN and the relationships obtained with the 
Chi-square test. The presence of a pink line between a pair indicates a 
relationship found with the Chi-square test but not present in the BN; the pink 
cross-shaped marker over an arc indicates that the underlying relationship was 
not detected by the Chi-square test. 
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4.5.2 Cardiac Risk Factors (CRF) Database 
Figure 4.10 shows the BN obtained for CRF dataset. Twenty-six arcs were 
inferred: 
1. Gender → High Blood Pressure 
2. Gender → Obesity 
3. Gender → Diabetes 
4. Gender → Smoking 
5. Gender → Disease 
6. Gender → High Cholesterol 
7. High Cholesterol → Disease 
8. High Cholesterol → Diabetes 
9. High Cholesterol → Smoking 
10. Triglycerides → High Cholesterol 
11. Triglycerides → Smoking 
12. Triglycerides → Disease 
13. Triglycerides → Obesity 
14. Triglycerides → Diabetes 
15. Heredity → Smoking 
16. Heredity → Triglycerides 
17. Smoking → Diabetes 
18. Smoking → Obesity 
19. Smoking → Disease 
20. Smoking → High Blood Pressure 
21. Diabetes → Obesity 
22. Diabetes → Disease 
23. Diabetes → High Blood Pressure 
24. Obesity → High Blood Pressure 
25. Obesity → Disease 
26. High Blood Pressure → Disease 
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Figure 4.10. Bayesian Network obtained for the variables in the CRF dataset. 
 
Except the “Heredity”, all the risk factors are parents of the node “Disease”, 
indicating their importance in the development of cardiac disease. Most arcs 
have a scientific explanation and literature data support them. By way of 
example, three of the “expected” arcs and the relative reference are after-
specified: 
- Gender → High Blood Pressure: ref [57] 
- Gender → Obesity: ref [58] 
- Gender → Diabetes: ref [59]; 
Table 4.6 shows the all the pairs of variables for which the Chi-square Test was 
significant.  
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Table 4.6.  Significant relationships obtained with the Chi-square test. 
Pairs Chi -square P 
Gender - Heredity 6.45 0.011 
Gender - Smoking 485.92 <0.0001 
Gender - Obesity 68.93 <0.0001 
Gender - Diabetes 7.37 0.007 
Gender - High Blood Pressure 40.01 <0.0001 
Gender - Cholesterol 4.58 0.032 
Gender – Triglycerides 12.17 <0.0001 
Gender – Disease 245.67 <0.0001 
Heredity - Smoking 27.01 <0.0001 
Heredity - Obesity 6.52 0.01 
Heredity - Cholesterol 17.06 <0.0001 
Heredity – Triglycerides 5.97 0.015 
Heredity – Disease 10.98 0.001 
Smoking - High Blood Pressure 43.28 <0.0001 
Smoking - Cholesterol 10.30 0.001 
Smoking – Triglycerides 18.39 <0.0001 
Smoking – Disease 105.52 <0.0001 
Obesity - Diabetes 87.69 <0.0001 
Obesity - High Blood Pressure 62.09 <0.0001 
Obesity - Cholesterol 12.25 <0.0001 
Obesity – Triglycerides 44.08 <0.0001 
Obesity – Disease 9.09 0.003 
Diabetes - High Blood Pressure 32.81 <0.0001 
Diabetes - Cholesterol 8.93 0.003 
Diabetes – Triglycerides 17.73 <0.0001 
High Blood Pressure - Cholesterol 19.53 <0.0001 
High Blood Pressure – Disease 8.56 0.003 
Cholesterol – Triglycerides 377.47 <0.0001 
Cholesterol – Disease 95.79 <0.0001 
Triglycerides – Disease 34.89 <0.0001 
 
Without considering the direction of the arc in the inferred BN and considering 
instead each arc as an indication of a relationship between the 2 variables, an 
acceptable agreement was found between the connections found with the 
approach here developed and the statistical test. With the chi-square test one 
important relationship not found by the BN approach was detected: heredity-
high cholesterol. On the other hand the chi-square didn’t detect the important 
link between the diabetes and the cardiac disease (figure 4.11).  
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Figure 4.11. Comparison for the CRF database between the relationships 
represented by an arc in the inferred BN and the relationships obtained with the 
Chi-square test. The presence of a green line between a pair indicates a 
relationship found with the Chi-square test but not present in the BN; the green 
cross-shaped marker over an arc indicates that the underlying relationship was 
not detected by the Chi-square test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Meloni Antonella                                                                                               Part I 
 
67 
5 Network topology 
 
As stated in the Introduction, one of the secondary aims of this thesis was to 
develop an algorithm able to automatically extract the main aspects of the 
inferred networks, in order to characterize them. 
In R there are already different packages containing functions for creating and 
modifying networks, assigning attributes to vertices and edges and calculating 
various structural properties. Some of them are: 
 igraph, which can be freely downloaded from the web site 
http://igraph.sourceforge.net/download.html; 
 network, which can be freely downloaded from the site http://cran.r-
project.org/web/packages/network/index.html.  
However, every package allows only limited data to be obtained. So, a more 
compact algorithm taking commands from both the packages and with new 
commands was developed.  
 
 
5.1 Network Representation 
A graph with N nodes is mathematically represented by means of the adjacency 
matrix. It is an NxN matrix A = (ai,j) with rows and columns labeled by graph 
vertices.  The entry ai,j =1 if there is an edge from vertex i to vertex j and is 0 if 
there is no edge from vertex i to vertex j.  
 
 
5.2 Extracted properties of the inferred networks 
All the network properties evaluated by the developed approach are described 
in the following. 
 
5.2.1 Nodes degree   
The degree of a node is the number of direct connections or edges it has to 
other nodes, that is the number of adjacent nodes. A vector with N elements is 
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constructed in which the i-th element of the vector represents the degree of the 
i-th node. 
Because the BN is a directed graph, then nodes have 3 different degrees: 
- in-degree: number of incoming edges,  
- out-degree:  number of outgoing edges,  
- total degree: total number of edges, both incoming and outgoing. 
So, three different vectors are obtained, one for each type of degree. 
 
5.2.2 Node-to-node distance 
Distance in networks is measured with the path length, which indicates how 
many links are need to pass through to travel between two nodes. As there are 
many alternative paths between two nodes, the shortest path - the path with the 
smallest number of links between the selected nodes - has a special role and 
represents the distance between the nodes, called even geodesic. When two 
nodes are identical, their distance is 0. When two nodes are unreachable from 
each other, their distance is defined to be infinity. In directed networks, the 
distance dij from node i to node j (shortest pat to the node j) is often different 
from the distance from j to i (shortest pat from the node j). A matrix NXN, in 
which the element i,j is the distance from the node i to the node j is inferred. 
This can be considered the matrix of the shortest paths from the given vertices. 
 
5.2.3 Mean path length 
The mean path length represents the average over the shortest paths between 
all pairs of nodes and offers a measure of a network’s overall navigability. It 
indicates the overall efficiency of the communication within the network, 
because it says how many steps on average are needed to move between any 
two points of the graph (less distance = more efficiency). It is calculated as: 
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5.2.4 Reachability  
A node i is reachable from a node j if a path from i to j is present.  To represent 
the reachability property of a system of interest in a very simple  way, the 
reachability matrix is built. The reachability matrix is a square matrix NXN, 
whose the generic element rij = 1 if there is at least one path, without any 
conditions on its length between the nodes i and j, 0 otherwise. Since each 
point reaches itself with anything sequence, rii = 0. 
 
5.2.5 Closeness  
The closeness is a measure based on the distance, which focuses its attention 
on how close a node is to the other ones. A node is the most central when it is 
able to quickly interact (having less intermediaries) with the others. Different 
types of paths can be used for measuring the distance in directed graphs: paths 
to a vertex, paths from a vertex or undirected paths. The closeness of a vertex 
is defined by the inverse of the average length of the shortest paths to/from all 
the other vertices in the graph. 
The path from the node i to the node j is considered for the distances 
calculation and so even for the closeness obtained considering the shortest 
path. 
A vector with N elements, with the i-th element representing the closeness of 
the i-th node is constructed. Because three measures of closeness can be 
obtained depending to the considered path, three distinct vectors are finally 
obtained. 
 
5.2.6 Betweenness  
The interaction between two non-adjacent nodes is linked to the collaboration 
with the other nodes, in particular with those ones located on the paths between 
them. These intermediaries have a delicate role and may exercise a power of 
control over the flow of information within the network. The concept of 
betweenness counts how many times each vertex is involved in the paths 
between other couples of nodes. 
The betweenness of the k-th node is the sum of all the partial betweenness 
evaluated for each nodes pair. 
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If gjk is the number of geodesics linking the nodes i and k in a graph, and gjk(i) is 
the number of such paths that contain the node i,  then 
 
jk
jk
jk g
ig
ib
)()( =
                (5.2) 
 
is the proportion of geodesics linking j and k  that contain i. 
To determine the centrality of  the node i, all these values for all unordered pairs 
of points where j < k and i #j # k mast be summed: 
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              (5.3) 
 
A vector with N elements in which the i-th element is the betweenness of the i-th 
node is obtained. 
 
5.2.7 Centrality 
There are various measures of the centrality of a vertex that determine its 
relative importance within the graph: 
- degree centrality: the central node is that one with the higher degree; 
- betweenness centrality: the central node is that one with the higher 
betweenness; 
- closeness centrality: the central node is that one with the higher closeness. 
 
5.2.8 Clustering Coefficient  
The clustering coefficient measures the degree with which nodes tend to cluster 
together. Evidence suggests that in most real-world networks, and in particular 
social networks, nodes tend to create tightly knit groups characterised by a 
relatively high density of links [60]. In real-world networks, this likelihood tends 
to be greater than the average probability of a tie randomly established between 
two nodes. 
The clustering coefficient of a graph is calculated as:      
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where Cj  is the clustering coefficient of the j-th node, given by: 
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kj are the arcs of the node j, connecting it to as many nodes. These nodes are 
the neighbors of the node j. ki (ki-1) / 2 is the maximum number of edges that 
can exist between the neighbors of node j, when every neighbor of the node is 
connected to every other neighbor. Ej represents the actual number of edges 
between the neighbors of the node j. The clustering coefficient is a quantity 
between 0 and 1.  
 
 
5.3 Practical example 
The topologic properties obtained for the ASIA Network are indicated in the 
sequel as example. The data are reported in the same way they appear in the R 
Console. For the sake of simplicity, the graph plotted with R is shown in Figure 
5.1.  
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Figure 5.1. Screen shot of the ASIA Network plotted with R. 
 
 Adjacency matrix for the network. 
       [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]   
[1]    0    0    1    0    0    0    0    0 
[2]    0    0    0    1    1    0    0    0 
[3]    0    0    0    0    0    1    0    0 
[4]    0    0    0    0    0    1    0    0 
[5]    0    0    0    0    0    0    0    1 
[6]    0    0    0    0    0    0    1    1 
[7]    0    0    0    0    0    0    0    0 
[8]    0    0    0    0    0    0    0    0 
Each number corresponds to a node, according to the model: 
1 → "VisitAsia"     
2 → "Smoking"       
3 → "Tuberculosis"  
4 → "Cancer"        
5 → "Bronchitis"   
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6 → "TbOrCa"        
7 → "XRay"          
8 → "Dyspnea. 
 
 Degree of the nodes. 
 In-degree: 
[1] "VisitAsia"    "0"  
[2] "Smoking"      "0"  
[3] "Tuberculosis" "1"  
[4] "Cancer"       "1"  
[5] "Bronchitis"   "1"  
[6] "TbOrCa"       "2"  
[7] "XRay"         "1"  
[8] "Dyspnea"      "2"  
 Out-degree: 
[1] "VisitAsia"    "1"   
[2] "Smoking"      "2"   
[3] "Tuberculosis" "1"   
[4] "Cancer"       "1"   
[5] "Bronchitis"   "1"   
[6] "TbOrCa"       "2"   
[7] "XRay"         "0"   
[8] "Dyspnea"      "0"   
 Total-degree 
[1] "VisitAsia"    "1"   
[2] "Smoking"      "2"   
[3] "Tuberculosis" "2"   
[4] "Cancer"       "2"   
[5] "Bronchitis"   "2"   
[6] "TbOrCa"       "4"   
[7] "XRay"         "1"   
[8] "Dyspnea"      "2"   
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 Matrix of the shortest paths from a given vertices to the other ones. 
       [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8] 
[1]    0  Inf    1  Inf  Inf    2    3    3 
[2]  Inf    0  Inf    1    1    2    3    2 
[3]  Inf  Inf    0  Inf  Inf    1    2    2 
[4]  Inf  Inf  Inf    0  Inf    1    2    2 
[5]  Inf  Inf  Inf  Inf    0  Inf  Inf    1 
[6]  Inf  Inf  Inf  Inf  Inf    0    1    1 
[7]  Inf  Inf  Inf  Inf  Inf  Inf    0  Inf 
[8]  Inf  Inf  Inf  Inf  Inf  Inf  Inf    0 
 
 Mean path length  
L = 1.722222 
 
 Reachability  Matrix. 
       [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8] 
[1]    1    0    1    0    0    1    1    1 
[2]    0    1    0    1    1    1    1    1 
[3]    0    0    1    0    0    1    1    1 
[4]    0    0    0    1    0    1    1    1 
[5]    0    0    0    0    1    0    0    1 
[6]    0    0    0    0    0    1    1    1 
[7]    0    0    0    0    0    0    1    0 
[8]    0    0    0    0    0    0    0    1 
 
 Closeness.  
[1] "VisitAsia"    "0.212121212121212" 
[2] "Smoking"      "0.28"              
[3] "Tuberculosis" "0.189189189189189" 
[4] "Cancer"       "0.189189189189189" 
[5] "Bronchitis"   "0.142857142857143" 
[6] "TbOrCa"       "0.166666666666667" 
[7] "XRay"         "0.125"             
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[8] "Dyspnea"      "0.125"             
 
 Betweenness.  
[1] "VisitAsia"    "0"         
[2] "Smoking"      "0"         
[3] "Tuberculosis" "3"         
[4] "Cancer"       "2"         
[5] "Bronchitis"   "1"         
[6] "TbOrCa"       "7"         
[7] "XRay"         "0"         
[8] "Dyspnea"      "0"         
 
 Centrality 
 Total degree centrality. 
Central node: "TbOrCa". 
 Closeness centrality.  
Central node: "Smoking" .    
 Betweenness centrality. 
Central node: "TbOrCa" 
 
 Clustering Coefficient. 
C=0.25.  
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            6 Evaluation of different 
network scores: results 
 
6.1 Introduction 
As stated in the Introduction, the other secondary aim of this thesis was the 
comparison of the BDe score, the score used in this context, with some other 
network scores existing in the literature.  
We considered the following scores: 
 K2; 
 Log-likelihood (loglik); 
  Akaike Information Criterion score (AIC); 
  Bayesian Information Criterion score (BIC). 
 
 
6.2 Performance of the different scores 
The S&S+ ARACNE approach, resulted the best one, was run using the 
different network scores with ASIA, CANCER and BN datasets.  
Table 6.1 and figure 6.1 report the results obtained for ASIA network. The best 
results were obtained with the BDe score, followed by the penalized likelihood 
scores (in order: BIC and AIC). The K2 and the Loglike scores resulted to be 
equally performative. 
The results for CANCER network are shown in Table 6.2 and in figure 6.2 . The 
BDe score was even in this case the best score. It is equaled by the BIC score 
for a sample of at least 5000. For this DB size, these two scores allowed the 
reconstruction of the true structure network. Considering the remaining scores, 
the following list can be drawn up: AIC, K2 and Loglik. 
The results obtained for BN Network are indicated in Table 6.3 and in figure 6.3. 
The BDE and the BIC scores resulted to be comparable in terms of 
performance and allowed to found the true network for each size of the 
database. Classifying in terms of performance, the following ordered list of the 
remaining scores can be drawn up: AIC, k2 and Loglik.  
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The possible weak point of a score was its precision, linked to the presence of 
FPs.  
The general trend for all the scores was that the networks learned were more 
and more accurate as the size of the datasets gradually enlarged.  
 
Table 6.1. Experimental results for ASIA network with different sizes using the 
different network scores. 
Sample size 
                             Score 
 Performance 1000 5000 10000 
Correct arcs 
or True 
Positive 
BDe 
K2 
Loglik 
AIC 
BIC 
8 
8 
8 
7 
7 
8 
8 
8 
7 
7 
8 
8 
8 
8 
8 
Incorrect 
added arcs or 
False Positive 
BDe 
K2 
Loglik 
AIC 
BIC 
1 
20 
20 
3 
1 
0 
19 
19 
3 
1 
0 
18 
18 
3 
0 
True Negative 
BDe 
K2 
Loglik 
AIC 
BIC 
55 
36 
36 
53 
55 
56 
37 
37 
53 
55 
56 
38 
38 
53 
56 
Missing arcs 
or False 
Negative 
BDe 
K2 
Loglik 
AIC 
BIC 
0 
0 
0 
1 
1 
0 
0 
0 
1 
1 
0 
0 
0 
0 
0 
Accuracy 
BDe 
K2 
Loglik 
AIC 
BIC 
0.98 
0.69 
0.69 
0.94 
0.97 
1 
0.70 
0.70 
0.94 
0.97 
1 
0.72 
0.72 
0.95 
1 
Precision 
BDe 
K2 
Loglik 
AIC 
BIC 
0.89 
0.29 
0.29 
0.70 
0.88 
1 
0.29 
0.29 
0.70 
0.88 
1 
0.31 
0.31 
0.73 
1 
Recall 
BDe 
K2 
Loglik 
AIC 
BIC 
1 
1 
1 
0.88 
0.88 
1 
1 
1 
0.88 
0.88 
1 
1 
1 
1 
1 
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Figure 6.1. F-score and Jaccard’s coefficient for ASIA network with different 
sample size using the different network scores. 
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Table 6.2. Experimental results for CANCER network with different sizes using 
the different network scores. 
Sample size 
                                 Score 
 Performance 1000 2500 5000 
Correct arcs 
or True 
Positive 
BDe 
K2 
Loglik 
AIC 
BIC 
5 
4 
3 
4 
4 
5 
4 
5 
4 
4 
5 
4 
5 
5 
5 
Incorrect 
added arcs or 
False Positive 
BDe 
K2 
Loglik 
AIC 
BIC 
1 
2 
7 
2 
1 
0 
1 
5 
1 
1 
0 
1 
5 
1 
0 
True Negative 
BDe 
K2 
Loglik 
AIC 
BIC 
19 
18 
13 
18 
19 
20 
19 
15 
19 
19 
20 
19 
15 
19 
20 
Missing arcs 
or False 
Negative 
BDe 
K2 
Loglik 
AIC 
BIC 
0 
1 
2 
1 
1 
0 
1 
0 
1 
1 
0 
1 
0 
0 
0 
Accuracy 
BDe 
K2 
Loglik 
AIC 
BIC 
0.96 
0.88 
0.64 
0.88 
0.92 
1 
0.92 
0.80 
0.92 
0.92 
1 
0.92 
0.80 
0.96 
1 
Precision 
BDe 
K2 
Loglik 
AIC 
BIC 
0.83 
0.67 
0.30 
0.67 
0.80 
1 
0.80 
0.50 
0.80 
0.80 
1 
0.80 
0.50 
0.83 
1 
Recall 
BDe 
K2 
Loglik 
AIC 
BIC 
1 
0.80 
0.60 
0.80 
0.80 
1 
0.80 
1 
0.80 
0.80 
1 
0.80 
1 
1 
1 
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Figure 6.2. F-score and Jaccard’s coefficient for all the algorithms on CANCER 
network by varying the sample size. 
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Table 6.3. Experimental results for BN network with different sizes using the 
different network scores. 
Sample size 
                                    Score 
 Performance 1000 5000 10000 
Correct 
arcs or True 
Positive 
BDe 
K2 
Loglik 
AIC 
BIC 
5 
4 
5 
5 
5 
5 
4 
5 
5 
5 
5 
4 
5 
5 
5 
Incorrect 
added arcs 
or False 
Positive 
BDe 
K2 
Loglik 
AIC 
BIC 
0 
1 
10 
1 
0 
0 
1 
10 
1 
0 
0 
1 
2 
1 
0 
True 
Negative 
BDe 
K2 
Loglik 
AIC 
BIC 
31 
30 
21 
30 
31 
31 
30 
21 
30 
31 
31 
30 
29 
30 
31 
Missing 
arcs or 
False 
Negative 
BDe 
K2 
Loglik 
AIC 
BIC 
0 
1 
0 
0 
0 
0 
1 
0 
0 
0 
0 
1 
0 
0 
0 
Accuracy 
BDe 
K2 
Loglik 
AIC 
BIC 
1 
0.94 
0.72 
0.97 
1 
1 
0.94 
0.72 
0.97 
1 
1 
0.94 
0.94 
0.97 
1 
Precision 
BDe 
K2 
Loglik 
AIC 
BIC 
1 
0.80 
0.33 
0.83 
1 
1 
0.80 
0.33 
0.83 
1 
1 
0.80 
0.71 
0.83 
1 
Recall 
BDe 
K2 
Loglik 
AIC 
BIC 
1 
0.80 
1 
1 
1 
1 
0.80 
1 
1 
1 
1 
0.80 
1 
1 
1 
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Figure 6.3. F-score and Jaccard’s coefficient for all the algorithms on CANCER 
network by varying the sample size. 
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Conclusion 
 
This part of my thesis focused upon Bayesian Networks, largely used in 
medicine to assist in the diagnosis of disorders, to predict the natural course of 
disease or outcome after treatment (prognosis), to determine the optimal 
treatments of a disorder in patients, and to predict outcome in groups of patients 
[1, 3].  
The main goal of this thesis was to develop a method for BNs structure learning 
able to increase the precision of the classical search and score approach, 
implemented in R in the package DEAL. The developed algorithm (S&S+MI 
preconditioning technique) first reconstructs a sort of the skeleton of the 
Bayesian Network in which the ones indicate the admitted edges (without 
considering the direction). The construction of the skeleton gets through the 
definition of a Mutual Information Matrix and its binarization. Four different 
binarization methods are implemented:  the use of a threshold based on the MI 
percentiles, the MRMR method, the ARACNE method and the CLR method. 
The MI binary matrix is exploited as a pre-conditioning step for the subsequent 
greedy search procedure that optimizes the network score, reducing the 
number of possible search paths in the greedy search [8, 9, 10]. Our strategy 
has been numerically investigated by means of four datasets (three constituted 
by discrete variables and one by continuous variable, discretized before the MI 
calculation) and compared against the metric implemented in the DEAL 
package. First of all the best threshold to be used for the MIM binarization was 
detected: the 50th percentile. This value was adopted in all the subsequent 
comparisons. Our algorithm always outperformed the DEAL metric, allowing to 
obtain networks very close to the real ones, used to create the corresponding 
databases. Moreover, the obtained reduction of the structure space dimension 
allowed the speeding up of the learning process. In general, the best results 
were obtained when ARACNE was used as binarization strategy. Moreover, the 
use of larger datasets led to better networks. The developed approach worked 
well even with real medical databases. 
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In all the performance analyses, always the same score was used to measure 
the goodness (fitness with the data) of each explored structure from the space 
of feasible solutions. The adopted score was the BDe, which is the score 
originally adopted in DEAL. This is only one of the possible network scores, so 
an other important goal of this thesis was to compare the performances of five 
types of score metrics, two belonging to the Bayesian scoring functions 
category (BDe and K2) and three to the information-theoretic scoring functions 
category. The experimental results showed that the best score was the BDe, 
followed by the BIC. The Loglik was the worst metric, affected by an high 
number of false positives.   
In parallel, an algorithm able to mathematically characterize the topology of the 
inferred network was developed. This might be important because structure 
always affects function.  
In summary, the successful numerical findings suggest that the S&S+MI 
preconditioning technique could be very useful in medical as well as in other 
different domains, especially when ARACNE is used as binarization method 
and the BDe is chosen as metric.  
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Abstract 
 
An algorithm able to perform the analysis of Illumina microRNA microarray data 
in a systematic and easy way was developed. The algorithm includes 2 parts. 
The first part is the pre-processing, characterized by two steps: variance 
stabilization and normalization. Variance stabilization has to be performed to 
abrogate or at least reduce the heteroskedasticity while normalization has to be 
performed to minimize systematic effects that are not constant among different 
samples of an experiment and that are not due to the factors under 
investigation. Three alternative variance stabilization strategies and three 
alternative normalization approaches are included. So, considering all the 
possible combinations between variance stabilization and normalization 
strategies, 9 different ways to pre-process the data are obtained. The second 
part of the algorithm deals with the statistical analysis for the differential 
expression detection. Linear models and empirical bayes methods are used. 
The final result is the list of the microRNAs significantly differentially-expressed 
in two different conditions. 
The algorithm was tested on three different real datasets and partially validated 
with an independent approach (quantitative real time PCR).  Moreover, the 
influence of the use of different preprocessing methods on the discovery of 
differentially expressed microRNAs was studied and a comparison among the 
different normalization methods was performed. This is the first study 
comparing normalization techniques for Illumina microRNA microarray data.  
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Introduction 
 
MicroRNAs constitute a large class of small regulatory RNAs [1]. They have 
diverse expression patterns and might regulate various developmental and 
physiological processes. Misregulation of miRNA function might contribute to 
human disease [2]. So, determining spatial and temporal patterns of microRNA 
expression should yield insight into the biological functions of microRNAs. The 
Microarray technology allows the determination of the expression of all known 
microRNAs simultaneously under any set of experimental conditions or 
constraints. Due to cost effectiveness and accuracy, the Illumina microarray 
(BeadArray) has became a popular microarray  platform [3]. The Illumina 
BeadArray  technology is based on randomly arranged beads, with each bead 
binding many identical copies of an oligonucleotide-specific probe. The 
BeadArray is constructed  so  that  there  are  roughly 250 randomly positioned 
replicates on average for each type of bead. This redundant design yields 
higher confidence calls and more robust estimations compared with other types 
of microarrays. However, the uniqueness of Illumina microarray design makes 
preprocessing  and  quality control steps significantly different from other types 
of microarrays [4].  
To date, a couple of packages are available in R for the analysis of Illumina 
Microarray data. However, they have been used only for the analysis of DNA 
Microarray data. Moreover, each package allows to perform only a limited 
number of operations. So, the first aim of this thesis has been the 
implementation of a complete algorithm for the analysis of microRNA microarray 
data through the modification, adaptation and union of the existent packages 
and the integration with new features.  
It is well known in the microarray community that pre-processing of microarray 
data is critical to obtaining valid results in terms of differential expression. 
Variance stabilization has to be performed to abrogate or at least reduce the 
heteroskedasticity, that is the violation of a constant variance across the 
measurement range [5]. Normalization has to be performed to minimize 
systematic effects that are not constant among different samples of an 
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experiment and that are not due to the factors under investigation (e.g. 
treatment, time) [6]. Various approaches are available for both variance 
stabilization and normalization purposes. Some of them have been included in 
the developed algorithm, so an other goal of this work has been to find out the 
impact of different pre-processing approaches on the detection of differentially 
expressed microRNAs. 
Finally, the performance of the different normalization methods for the Illumina 
BeadChip technology has been compared. 
To test the developed algorithm and reach the fixed goals, three different real 
datasets have been used.  
The remainder of this thesis is organized as follows.  
Chapter 1 provides some biological background. 
Chapter 2 is focused on the biological methods and protocol adopted.  
Chapter 3 describes all the steps of the developed algorithm. It represents the 
methodological part. 
Chapter 4 presents the results of this thesis. 
Chapter 5 draws together and summarizes the major conclusions of this study. 
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1 MicroRNA and analysis of 
differential expression  
 
1.1 Brief outline of RNA’s structure 
Along with deoxyribonucleic acid (DNA) and proteins, ribonucleic acid (RNA) 
represents one of the three major macromolecules that are essential for all 
known forms of life. 
RNA is made up of a long chain of components called nucleotides [7]. Each 
nucleotide consists of (figure 1.1): 
- a ribose sugar, with carbons numbered 1' through 5'; 
- a nucleobase, attached to the 1' position, generally adenine (A), cytosine (C), 
guanine (G) or uracil (U); 
- a phosphate group attached to the 3' position of one ribose and the 5' position 
of the next. The phosphate groups have a negative charge at physiological pH, 
making RNA a charged molecule (polyanion). 
Unlike DNA, most RNA molecules are single-stranded. Single-stranded RNA 
molecules adopt very complex three-dimensional structures, since they are not 
restricted to the repetitive double-helical form of double-stranded DNA [8]. RNA 
is made within living cells by RNA polymerases, enzymes which act to copy a 
DNA or RNA template into a new RNA strand through processes known as 
transcription or RNA replication, respectively. 
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Figure 1.1. Chemical structure of RNA. 
 
 
1.2 MicroRNA 
 
1.2.1 Structure and basic function 
MicroRNAs (miRNAs) are short RNA molecules, on average only 22 
nucleotides long. Although miRNAs were initially discovered in the nematode C. 
elegans [9], they have subsequently been found in various organisms and are 
thought to be expressed in all metazoan eukaryotes [10].  
MiRNAs are post-transcriptional regulators that bind to complementary 
sequences on target messenger RNA (mRNA) transcripts (key intermediaries in 
gene expression, translating the DNA's genetic code into the amino acids that 
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make up proteins), usually resulting in translational repression and gene 
silencing [1].  
More than 850 mature miRNA sequences have been identified in humans, and 
although this accounts for less than 2% of human genes, it is predicted that 
30% of mRNAs are targeted by miRNAs [11].  
 
1.2.2 Biogenesis and action 
MicroRNAs are transcribed for the most part by RNA polymerase II as long 
primary transcripts characterized by hairpin structures (pri-microRNAs) and 
processed into the nucleus by RNAse III Drosha into 70- to 100-nts long 
premicroRNAs. These precursor molecules are exported by an Exportin 5-
mediated mechanism to the cytoplasm, where an additional step mediated by 
the RNAse III Dicer generates a dsRNA of approximately 22 nts, named 
miR/miR*. The mature single-stranded microRNA product is then incorporated 
in the complex known as microRNA-containing ribonucleoprotein complex 
(miRNP), miRgonaute, or microRNA-containing RNA-induced silencing complex 
(miRISC), whereas the other strand is likely subjected to degradation. In this 
complex, the mature microRNA is able to regulate gene expression at the post-
transcriptional level, binding through partial complementarities for the most part 
to the 3′UTR of target mRNAs. It has been demonstrated that if there is 
complete complementation between the miRNA and target mRNA sequence, 
the mRNA can be cleaved leading to direct mRNA degradation. Yet, if there isn't 
complete complementation the silencing is achieved by preventing translation 
[12] (Figure 1.2). 
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Figure 1.2. Biogenesis, processing, and maturation of microRNAs. 
 
1.2.3 MiRNAs as regulator of important biological processes 
The importance of faithful miRNA expression has been implicated in numerous 
biological and cellular events. The miRNA let-7 is critical for developmental 
timing [13], a developmentally regulated miRNA (bantam) controls cell 
proliferation via regulation of apoptosis [14], and miRNAs control embryonic 
stem (ES) cell differentiation [15] and stem cell division [16]. Other examples 
are miR-196, which is involved in hind limb development [17], and the brain-
specific miR-134, which contributes to the spatiotemporal control of mRNA 
translation that is necessary for synaptic development and plasticity [18]. Skin 
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differentiation is promoted by miR-203, which represses p63 in stratified 
epithelial tissues [19], while precise levels of miR-1 are critical in cardiogenesis 
[20]. Normal immune function is dependent on miR-155 [21] and B-cell 
differentiation is controlled by miR-150 mediated repression of the transcription 
factor c-Myb [22]. In addition, the pancreatic islet cell-specific miR-375 regulates 
insulin secretion by inhibiting myotrophin, a component of the exocytosis 
pathway [23]. 
 
1.2.4 MiRNA and disease 
MiRNAs dysregulation may play causative roles in several diseases. In 
neurological diseases, the loss of the miR-20a/b-1 cluster is implicated in 
Alzheimer’s disease [24] and the loss of miR-133b may contribute to the 
decrease in dopaminergic neurons seen in Parkinson’s disease [25]. Other 
studies found altered miRNA expression in schizophrenia [26]. 
MiRNA misexpression has been well documented in cancer. The first high-
throughput study using 334 patient samples of various malignancies has 
showed that miRNA profiles can distinguish the developmental lineage and 
differentiation state of the tumors [27]. Another report has been able to identify 
the tissue of origin of metastatic tumors with unknown primary origin based on 
the miRNA profiles [28]. Profiling experiments have established miRNA 
deregulation in various cancers including pancreatic cancer [29], liver cancer 
[30], breast cancer [12], colorectal cancer [31], neuroblastoma[32], prostate 
cancer [33], bladder cancer [34], cervical cancer [35], leukemias [36], lung 
cancer [37], esophageal cancer [38], ovarian cancer [39], thyroid cancer [40], 
and sarcomas [41]. Intriguingly, many of these studies show that miRNA 
signatures have diagnostic and prognostic value, and may become valuable 
clinical tools in cancer therapy [42]. 
In heart disease, the expression of miR-21 in cardiac fibroblasts contributes to 
interstitial fibrosis and cardiac hypertrophy [43], while miR-1 and miR-133 in 
cardiomyocytes protect against hypertrophy [44].  
As a defence against viral infection, interferon-β upregulates miRNAs that target 
hepatitis C virus RNA and decrease replication and infection [45]. 
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On the other hand, during latent infection herpes simplex virus 1 expresses 
miRNAs that target viral transcripts [46], so miRNAs have evolved to play roles 
in both aiding viruses and defending against them. 
 
1.2.5 Analysis of miRNA expression 
Reliable and accurate techniques for analyzing the global expression pattern of 
miRNA are critical for understanding their role in regulating gene expression 
and controlling both normal and pathological processes. Several approaches 
are available for simultaneously profiling large numbers of miRNAs, including 
multiplex reverse transcription polymerase chain reaction (RT-PCR) based 
analysis, bead-based flow cytometry assay, and microarrays [47]. 
 
 
1.3 Microarray-based miRNA profiling 
 
1.3.1 Principle 
MicroRNA microarray  technology  is  actually  based  on nucleic  acid  
hybridization between target molecules and their corresponding  
complementary  probes.  A  schematic flow chart of the microRNA profiling 
microarray is shown in Figure 1.3.  
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Figure 1.3. The principle of the microRNA profiling microarray. (a) Amine-
reactive glass slides. (b) Amine-modified microRNA probes that consist of 
“linker” sequences (in purple) and capture sequences (in green). (c) Ready-to-
use slides of the microRNA microarray. (d) Samples (cells, tissues). (e) Isolated 
microRNAs. (f) MicroRNAs labeled with fluorescence dye. 
 
MicroRNA oligonucleotide probes that usually have amine-modified 5′ termini 
are immobilized onto glass slides  through  covalent  crosslinking  between  the  
amino groups and the SAM (self-assembling monolayer), forming a ready-to-
use microRNA microarray. The microRNAs isolated from the samples of interest 
are labeled with fluorescent dye and then they are hybridized with the  
microRNA  microarray,  resulting  in  specific binding  of  the  labeled  
microRNAs  to  the corresponding probes. A high number of complementary 
base pairs in a nucleotide sequence means tighter non-covalent bonding 
between the two strands. After washing off of non-specific bonding sequences, 
only strongly paired strands will remain hybridized. So fluorescently labeled 
target sequences that bind to a probe sequence generate a signal that depends 
on the strength of the hybridization determined by the number of paired bases, 
the hybridization conditions (such as temperature), and washing after 
hybridization. The  fluorescence  emission  from  labeled  microRNAs  bound  at  
different  positions  on  the  slides  can  be detected. Consequently, the kinds of 
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microRNAs and their relative quantities in the studied sample can be evaluated 
by analyzing the fluorescence signal data [48]. 
 
1.3.2 Optimal Design 
The ideal design of microarray experiments consists in having as many 
replicates as possible. Replicates allow  for  assessment  of  variation  in  
expression  data  so  that formal  statistical  analysis  methods  can  be  applied.  
Without  replicates,  one cannot  distinguish  between  true  differences in 
nucleotide expression versus random  fluctuations.  Replicates  can  take  place  
at  different  levels  of  the experiment.  Yang  and  Speed [49] described  two  
types  of replication:  biological  replicates  and  technical replicates.   
An example of biological replicates is a set of hybridizations that involve  
oligonucleotides from different extractions, that is multiple independent samples 
for each treatment are prepared.  
Technical  replicates  include  replicates  in  which  the oligonucleotide  is  from  
the  same  pool  (the  same  extraction). The technical replicates may be two 
independent RNA extractions or two aliquots of the same extraction. Examples 
are more than one array used to test a single sample or multiple spots of the 
same probe, such as duplicate spotting.  
In general, an experimenter will use biological replicates to obtain averages of 
independent data, to assess the natural biological variance and to validate a  
generalization of the conclusion and technical replicates to detect variation  
within the experimental groups in order to assist in reducing experimental 
variability. 
 
1.3.3 Biological Protocol 
The design of the microRNA probes, the preparation of microRNA samples and 
the labeling of microRNAs are considered the most important  procedures  in  
the  microRNA  microarray  platform.  
 
MicroRNA probe design 
The  oligonucleotide  probes  used  in a microRNA  microarray usually consist 
of two parts: “linker” sequences and "capture" sequences. The “linker” 
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sequences often consist of poly(dT) or poly(dA) with an amine-modified 
terminus. In immobilized probes, the linker parts are close to the glass surface 
to minimize spatial obstacles during the hybridization of the probes with the 
target molecules. The "capture" sequences are usually complementary in 
sequence to the  microRNAs under investigation  [47]. 
 
Purification of miRNA 
Because the quality of expression analysis depends largely on the quality of the 
RNA used, robust and reproducible methods for the quantitative isolation of 
miRNA are essential. Different isolation methods that retain the small RNAs 
during total RNA isolation or enrich the small RNA population are now available. 
Further purification of the small RNA fraction improves the analysis of miRNA 
expression by reducing nonspecific hybridization to longer miRNA precursors, 
the homologous regions of target mRNAs, and other unrelated RNA species. A 
number of different methods exist for separating the small and large RNA 
fractions, including solid-phase extraction, microfiltration, reverse-phase or ion-
exchange chromatography and size fractionation using polyacrylamide gel 
electrophoresis (PAGE). The last one has now become the gold standard [31]. 
The yield of small RNAs is typically less than 1 ng per 10 pg of total RNA from 
mammalian tissue, whereas immortalized cell lines typically display much lower 
general miRNA expression than tissues. Approximately 5 million cells can yield 
up to 10 ug of total RNA, a sufficient amount for miRNA array analysis. 
 
Labeling of miRNA 
After isolation of the small RNAs, they must be labeled for detection on arrays.  
Many  different  labeling  methods  have  been developed,  and  they  can  be  
classified  into  two  main categories [48]:  
1) direct labeling, in which microRNA molecules  are  directly  conjugated  with  
fluorescent  dye;   
2) indirect labeling, in which the microRNA reverse transcript, the RT-PCR 
product of microRNA or the in vitro transcript of  microRNA,  are  labeled  
instead  of  the  microRNA molecule itself. 
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1.3.4 Microarray Platforms 
The process of constructing an array has a major impact on the type of 
experimental design and analysis that can be performed. Practically, the various 
array formats can be classified based on whether they support two-colour or 
one-colour analysis.  
For the two-colour microarrays, test and reference samples are each labeled 
with a specific fluorescent dye and cohybridized on the same array that is then 
scanned in a microarray scanner to visualize fluorescence of the two 
fluorophores after excitation with a laser beam of a defined wavelength. 
Relative intensities of each fluorophore may then be used in ratio-based 
analysis to identify up-regulated and down-regulated microRNAs [50]. 
In one-color microarrays, the arrays provide intensity data for each probe or 
probe set indicating a relative level of hybridization with the labeled target. 
However, they do not truly indicate abundance levels of a oligonucleotide but 
rather relative abundance when compared to other samples or conditions when 
processed in the same experiment. The comparison of two conditions for the 
same oligonucleotide requires two separate single-dye hybridizations. The 
major  strength of the single-dye system lies in the fact that an aberrant sample 
cannot affect the raw data derived from other samples, because each array chip 
is exposed to only one sample. Moreover, other data are more easily compared 
to arrays from different experiments so long as batch effects have been 
accounted for.  
 
1.3.5 Image analysis 
Image analysis is an important aspect of microarray experiments. It can have a 
potentially large impact on subsequent analysis such as the clustering or the 
identification of differentially expressed miRNAs. Fluorescence intensities are 
usually stored as 16-bit images which are viewed as ‘raw` data and are stored 
as TIFF (tagged image file format) files [51] (Figure 1.4). 
The processing of scanned microarray images can generally be separated into 
three tasks: 
- addressing: process of assigning coordinates to each spot; 
Meloni Antonella                                                                                             Part II           
 
107 
- segmentation: it allows the classification of pixels either as foreground - that is, 
within a printed microRNA spot - or as background; 
- intensity extraction: calculation for each spot on the array of foreground 
fluorescence intensity, background intensities and, possibly, quality measures. 
 
 
Figure 1.4. Sub-sector of two-colour microarray. Each spot represents a single 
nucleotide. Red spots indicate up-regulated microRNAs, green spots are down-
regulated microRNAs and spots that are yellow are unchanged between the 
experimental and control samples. 
 
1.3.6 Statistical measures of differential expression 
In the analysis of microarray experiments, many methods exist for the 
identification of genes or microRNAs that are differentially-expressed between 
conditions. Despite the wealth of available methods, biologists show a fondness 
for two of the earliest approaches, fold-change and the t-statistic, presumably 
because of their simplicity and interpretability. 
Let xij and yij denote the expression levels of gene i in replicate j in the treatment 
and control, respectively. The ordinary two-sample t-statistic can be defined as: 
 
i
ii
i
s
yxT −=       (1.1) 
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where si is the standard deviation of the replicates for gene i.  
There are two definitions of fold-change in the literature. The standard definition 
of the fold-change for molecule i is [52] : 
 
'
'
i
i
i y
xFC =           (1.2) 
 
On the other hand, in Guo et al. (38) the fold-change for gene i is defined as: 
 
''
iii yxFC −=          (1.3) 
 
Generally, the FC calculated with the equation 1.2 is used. Some practitioners 
replace a fold-change value that is less than 1 by the negative of its inverse. For 
example, a FC=0.25 corresponds to a FC=-4 (or in common terms, a four-fold 
decrease). A threshold is applied to the FC in order to define data points that 
are differentially expressed. Classically, a threshold equal to 2 is used, so that a 
FC>2 indicates an overexpression in respect to the control and a FC<-.2 
indicates an underexpression. Generally the logarithms of the intensities are 
taken. The threshold 2 corresponds to a ratio of 1 and –1 on a log2 scale. 
 
 
1.4 Real Time PCR 
 
1.4.1 PCR 
The polymerase chain reaction (PCR) is an in vitro molecular biology technique 
used to amplify DNA molecules [53], developed primarily by Kary Mullis (Nobel 
Prize, Chemistry 1993).  
The components of a PCR are:  
- DNA template: DNA source that contains the target region; 
- Deoxynucleoside triphosphates (dNTPs): monomeric building blocks of DNA. 
They are composed of a ribose sugar, three phosphate groups, and a base 
(Figure 1.5). The base component determines the type of nucleotide; 
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Figure 1.5. Chemical structure of nucleoside triphosphates. 
 
- DNA primers: short (20–100 bases) single stranded pieces of DNA that flank 
the target region within the DNA template. When they bind to the template, they 
define the starting point of amplification. The starting point of one strand is the 
ending point of its complimentary strand; 
- DNA Polymerase: enzyme that continues synthesis of a complementary strand 
of DNA. In the early implementations of PCR, E.Coli DNA polymerase (in 
particular, the Klenow fragment) was used. It was destroyed at the melting DNA 
temperatures (~95°C) and thus replaced after every cycle. The ideal 
temperature for synthesis using this polymerase was 37°C; however, this 
allowed primers to bind to noncomplementary regions thus reducing specificity. 
Biologists moved to Taq Polymerase I because it is thermally stable at 95°C. 
This move is considered by many as the most important development towards 
the wide usage of PCR [54]. Taq polymerase was originally isolated from 
Thermus aquaticus bacteria that live in hot springs and thus have polymerase 
that can withstand high temperatures. The enzyme has optimal activity around 
70–80°C, and a half life of about 10 minutes at 97° C [55]; 
- buffer solution: a solution which maintains the optimal pH and salt 
concentration values for efficient amplification. This solution is often purchased 
from a vendor in a pre-mixed form. It is typically a Tris-HCl buffer system 
around pH 8.4 with KCl and some MgCl2 already added. 
The typical thermal recipe is described below and showed in figure 1.6 . 
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1. 94°C for 2 minutes: initialization step. Special ly modified Taq polymerases 
which are designed for minimal activity at room temperature are activated. Also, 
during this step, which occurs only once in the reaction, the template DNA and 
primers fully dissociate.  
2. 94°C for 15-30 seconds: denaturation  step. The DNA targets (also called 
amplicons) produced during previous cycles dissociate by disrupting the 
hydrogen bonds between complementary bases. This exposes the bases and 
allows the primers to bind to them in the next step. 
3. 55°C for 15-30 seconds: annealing  step. The primers bind to their 
complementary sequences in the target DNA. 
4. 72°C for 15-30 seconds: extension  step. The DNA polymerase extends the 
DNA strand starting from the primers, assembling from the 5’ to 3’ end of the 
new DNA strand by adding the complementary dNTP to the elongating strand. 
5. Repeat steps 2-4 for about 30-40 cycles. After each cycle, the number of 
DNA molecules is theoretically doubled if 100% efficient. 
6. 72°C for 5 minutes: final elongation. This step is often performed at to ensure 
any remaining single-stranded DNA is fully extended. 
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Figure 1.6. PCR schematic illustrating selective amplification of the target region 
between the primer pairs. 
 
Following PCR, gel electrophoresis is used to determine if the anticipated DNA 
target has amplified. Using this technique, a DNA ladder (mixture of fragments 
of DNA of known size) is run alongside the PCR sample to obtain an estimate of 
the size of the product.  
The real time polymerase chain reaction or quantitative real time PCR (qrt-PCR) 
is a procedure based on PCR where a piece of target DNA is both amplified and 
quantified simultaneously. The quantification is possible thanks to the use of 
fluorescent indicators. One indicator is the SYBR Green. It binds to all double 
stranded DNA (at the working concentrations), so it can be used irrespective of 
target DNA sequence, making it versatile. As the number of double stranded 
DNA molecules increases, so does the fluorescence.  
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An alternative to SYBR Green is the family of TaqMan probes. These have the 
advantage of fluorescing only during the synthesis of the target DNA, thus 
adding another level of specificity. A schematic of the TaqMan probe system is 
shown in Figure 1.7. 
 
 
Figure 1.7. Schematic of TaqMan probes. 
 
In its free state, the green and red fluorophores are connected via the DNA 
bases between them. These bases are designed to be complementary to a 
sequence within the target DNA. The proximity allows Förster resonance energy 
transfer (FRET) to occur: the energy from the optically excited green 
fluorophore (donor molecule) transfers to the red fluorophore (acceptor 
molecule) which accepts and dissipates the energy as heat or light in a longer 
wavelength. During the annealing step of qrt-PCR, the TaqMan probe binds to 
its complementary sequence on the target DNA. During the extension step, as 
Taq DNA polymerase extends the target DNA, it destroys the seemingly 
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disruptive Taqman probe as it synthesizes the new strand. This allows the 
green fluorophore to become spatially separated from the red quenching 
molecule, thus emitting its green photons instead of participating in FRET. This 
increase in fluorescence is then measured by the qrt-PCR machine. 
PCR is a DNA-based analysis. The usage of DNA primers takes advantage of 
the naturally evolved base pairing phenomenon that provides excellent 
specificity. All organisms have DNA or RNA which can be converted to DNA. 
So, before the reaction starts, the strand of microRNA is reverse transcribed by 
the reverse transcriptase enzyme into the corresponding complimentary DNA 
(cDNA).  
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2 Biological methods 
 
2.1 Introduction 
This chapter is focused on the biological methods and protocol adopted. All the 
biological experiments were performed in the laboratories of the microRNA 
group of the Institute of Clinical Physiology, CNR in Pisa. 
First of all, there is a detailed description of the microarray platform employed. 
This is a key point because the specific design of the employed microarray 
leads to the creation of summary data which requires specific statistical 
treatment, different from that of more classical microarrays.  
Then, some aspects of the procedure adopted for the validation of microarray 
results are presented.  
Finally, the data sets used in this thesis are introduced. 
 
 
2.2 Illumina Microarray 
 
2.2.1 Structure 
Illumina BeadChips are available for human, mouse, and rat organisms and in 
multiplexed formats of 6, 8, 12 or more arrays per slide [3]. 3-micron silica 
beads are assembled in microwells on either of two substrates: fiber optic 
bundles or planar silica slides. When randomly assembled on one of these two 
substrates, the beads have a uniform spacing of ~5.7 microns. Each bead is 
covered with hundreds of thousands of copies of a specific oligonucleotide that 
act as the capture sequences in one of Illumina’s assays. Multiple copies of 
each bead type (up to 250 for the microRNA) are present in the array. This built-
in redundancy improves robustness and measurement precision. After random 
bead assembly, 29-mer address sequences present on each bead are used for 
a hybridization-based procedure to map the array, identifying the location of 
each bead.  
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Figure 2.1. Design of a randomly assembled gene-specific probe array. (A) 
Representation of an individual bead lodged in a well. Attached to the bead by 
its 5’ end is a chimeric oligonucleotide ~75 nucleotides in length, comprising an 
~25-nucleotide identifier sequence and a 50-nucleotide-specific probe. The 
bead identifier sequence is decoded using an algorithm described previously 
[56]. The drawing is not to scale; the relative size of the oligonucleotide  has  
been  vastly  exaggerated  to  show  its  features.  (B)  There  are~50,000 
beads in an ~1.4-mm diameter optical fiber bundle, each bead lodged in a well 
at the end of an individual fiber in the bundle. (C) The bundles are arranged in a 
96-array matrix matching the format of a standard microtiter plate. 
 
2.2.2 Illumina data 
Illumina’s scanning software (BeadScan) produces files (.idat, .locs etc) in 
proprietary format which are read by Illumina’s BeadStudio software. However, 
with modifications to BeadScan, standard (readable) files can be obtained for 
each array: 
- text file giving the identity and location of each individual bead (required); 
-TIFF images (optional). 
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Figure 2.2. Example of a Bead-level text file. 
 
BeadStudio software is used to read raw data and produce a single foreground 
intensity value for each bead type after outliers have been excluded and 
background has been removed. A single file is generated describing all arrays 
in the experiment with arrays listed along the page. This requires the analysis of 
original data, described in the sequel. 
 
2.2.3 Statistics of Illumina BeadChip datasets 
The bead intensity of a given microRNA in a BeadChip is described with the 
random variable X [57]. The expression profile experiment is supposed to 
consist of K technical replicates (independent measurement of arrays on the 
same biological sample). Each bead intensity xk,n  is an instance of the random 
variable X (where k=1...K replicates, n=1...Nk beads, Nk is the number of beads 
in the k-th technical replicate). The summary data includes the mean µk, the 
standard error (where σk is the standard deviation) and the number of beads. 
The observed BeadChip intensities of gene in the k-th array are denoted as: 
 
[ ]TNkkkk kxxxX ,2,1, ....=       (2.1) 
 
The Illumina BeadStudio software first performs an outlier removal on the bead 
intensities. Instances with intensities above three median absolute deviations 
from the median are removed. Upon the outlier removal, the mean and standard 
error of the bead intensities as well as the number of beads used in 
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summarization for each gene are reported (AVG_signal, BEAD_STDERR, 
Avg_NBEADS are the columns’ names in the Illumina Beadstudio output file). 
Using the means and standard errors of all the technical replicates, the mean 
µtotal and standard deviation σtotal of bead intensities of a microRNA across the K 
technical replicates are given as: 
 
∑
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The standard deviation σtotal is composed of two components each carrying a 
different meaning. Given that each of the K technical replicates represents the 
same, identical and independent distribution, one expects the K mean estimates 
µk to be relatively similar and, hence, σµ would be small relative to σtotal and, 
ideally, close to zero. Since averaging for each replicate is carried out over 
many individual measurements, it can be assumed that each individual µk is 
likely a good estimate of the population mean µ if there are no batch variations. 
Therefore, a large σµ can be interpreted as batch variation or noise among the 
replicates, a considerable part of which, apparently, has systematic origin such 
as variations in the total amount of hybridization-ready nucleic acids, etc. 
Ideally, K (typically 2–4) should be much larger in order to obtain a good 
estimate of σµ. However, this is impractical due to the high cost of performing 
large number of microarrays. Therefore, it is suggested to assume σµ≈0 for the 
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case of no batch variation and to use σwtrep as a good lower estimate of the 
summary statistic in testing instead of σµ. 
 
2
µσσ =total        (2.6) 
 
This proposed summary statistic is supported by different observations (4,58). 
 
2.2.4 Illumina detection P-value 
In addition to the average intensity of all beads, the standard error of the 
average intensity and the number of beads, the other column in the Illumina 
Beadstudio output file is the so called Detection_Pval, representing the p-value 
that the signal is above the background [59].  
In  calculating  the Illumina detection P-value, let k index the hybridized 
BeadArrays (samples), g index beadtypes or microRNAs, and bkg represent 
expression for beadtype g for the k-th array. Illumina includes control features 
on each BeadArray, such as negative control beadtypes which are randomly 
permuted sequences known not to exist. Let the N negative control beadtypes 
be represented by bnegkg , such that the mean of the negative control beadtypes 
for array k can be given by: 
 
∑
=
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N
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k bN 1
1µ)      (2.7) 
 
Similarly, the standard deviation of the negative control beadtypes for 
BeadArray k is calculated. 
Thereafter, a z-score is calculated for each gene on BeadArray k as: 
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These g z-scores are then ranked using a specialized function: 
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Thereafter, the detection call P-value for microRNA g on BeadArray k is given 
by: 
 
N
R
DPV kgkg −= 1        (2.10) 
 
Although  the  Illumina  BeadStudio does not provide a qualitative detection call, 
the use of an alpha level such as 0.05 or 0.01 for making Present/Absent calls 
is recommended. 
 
2.2.5 Packages for Illumina Microarray Data 
The  Bioconductor  project  is  an online  repository  of  open  source  software  
written  using  the R programming language [60]. The project aims to provide a 
range of  statistical  and  graphical  tools  for  analysing  genomics data.   
Different Bioconductor  packages have been  expressly developed for Illumina 
data, i.e Beadarray and Lumi. 
Beadarray  is  the  first  Bioconductor  package  written specifically for Illumina 
data [61]. It is able to read bead-level data (raw TIFFs and text files) from 
BeadScan as well as bead-summary data from BeadStudio. The access to 
bead-level data  offers the choice among different image processing and 
background correction methods and allows for detailed quality assessments to 
be carried out for each array.  
Lumi [62] provides unique functions for expression Illumina microarray 
processing: quality control, BeadArray-specific variance stabilization, 
normalization and gene annotation at the probe level. It also includes the 
functions of processing Illumina methylation microarrays, especially Illumina 
Infinium methylation microarrays.  
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Once an expression matrix is obtained, further data analysis can be performed 
as for other microarray technologies, using affy package or limma, which 
provides tools for linear modelling. Also clustering or PCA methods can be 
easily applied. 
 
 
2.3 Experimental Validation of Microarray Data 
The validation procedure is used as tool for confirming microRNA expression 
results obtained from microarray analysis. 
Two questions are commonly associated with the validation exercise. 
1. When should one perform an experimental validation?   
In essence, an experimental validation  should  be  performed  when  there  is  
a  need to independently establish the ‘robustness’ or ‘reliability’ of a microarray 
finding.   
2. Why should  one  perform  an  experimental  validation?   
Perhaps the  most  significant  reason is that microarray data is inherently noisy. 
The  large  numbers of oligonucleotides expression  measurements obtained in  
a  typical  microarray  experiment, by virtue of its sheer numbers, can often yield 
significant numbers of false positive and negative results.  Such artefacts can 
arise due  to numerous experimental and technical reasons, including: spurious 
signals caused by microarray probes cross-hybridizing to related  transcripts  of 
similar sequence similarity, mistakes in the assignment of probe identities, 
artefacts induced by the sample preparation technique (preferential enrichment 
of certain transcripts during RNA amplification procedures, degradation of  RNA  
during  the  extraction  process), and artefacts cause  by the hybridisation 
procedure itself. All these examples point to the fact that microarray technology 
is still very much an evolving field, and as such, it is essential to have the 
resources to perform at least a measure of independent validation of the  
microarray  result. In addition, it is also worth noting that in certain cases, the 
validation exercise may also lead to unexpected  novel  biological  findings. 
Thus, it would be a fallacy to regard such validation exercises as mere  
inconvenient confirmations of the microarray data.  
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The end result of a typical microarray experiment is the identification of a 
reduced number of microRNAs, selected from the initial global data set, that 
exhibit a particular  behavior  of  interest,  such  as  being  differentially  
regulated across a particular class distinction (eg cancer vs normal tissue), or 
being transcriptionally induced upon a drug treatment. This set of reduced 
genes is defined the ‘target set’.   
For  many  microarray  experiments,  the  numbers of  microRNAs  in  the 
‘target  set’  will  usually  still  be  too  large  for  every  single  target  set 
member to be experimentally validated. Candidate  members  of  the  target  set  
are selected for  further  experimental validation. The decision of which 
candidate members to select for validation is far from a  trivial  exercise  and  
can be dependent upon multiple factors, such as I) the magnitude of regulation, 
as microRNAs exhibiting dramatic patterns of differential regulation are more 
likely to be ‘truly’ regulated compared to those ones exhibiting  subtle  levels  of 
regulation), II) the absolute expression level in the cell or tissue, as abundantly 
expressed microRNAs are typically easier to measure, III)  the  prior availability 
of needed products; IV) scientific relevance to the hypothesis being tested.   
In the context of this thesis, the validations were usually performed on the same 
or  similar  biological samples (biological replicates) that were used to generate 
the original data.  The qtr-PCR, described in the previous chapter, was used for 
this purpose. The microRNAs for which the PCR primers were available were 
validated.  
 
 
2.4  Datasets  
Three different databases were used to test the developed algorithm and for the 
other goals of this work. 
 
Case study 1 
The data is from a study on the B cell lymphoma 6 (BCL6) transcriptional 
repressor. This is the most commonly involved proto-oncogene (normal gene 
which, when altered by mutation, becomes an oncogene that can contribute to 
cancer) in the diffuse large cell lymphoma (DLCL) [63]. 
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One of the aims of the above-mentioned study was to find the miRNAs 
regulated by BCL6, through the detection of the miRNA activated (up-
expressed) following the silencing of BCL6. 
All the experiments were performed on Dohh2 non-Hodgkin lymphoma cells. 
Dohh2 cells were transfected with either a control siRNA activator (ds-NC) or a 
siRNA against Bcl6. 
Specifically, four different samples were created: two controls, treated with 
control siRNA activator, and two treated samples, for which 2 different types of 
sirNA against Bcl6 were used. The total RNA was extracted from the cells in the 
samples and microRNAs were labeled and hybridized with the microarray. As a 
result, a dataset including 4 samples and 1145 microRNAs was obtained and 
used as input for the algorithm. Because two control samples were available, 
they were considered as a single group (g1). So, the following comparisons 
were performed: 
- treatment 1 vs control (g2 vs g1); 
- treatment 2 vs control (g3 vs g1). 
 
Case study 2 
The data is from a study on thyroid hormones (TH), which are critically 
important for development, tissue differentiation, and maintenance of metabolic 
balance in mammals through direct and indirect regulation of expression in 
target genes [64]. The liver plays a critical role in metabolism, serum glucose 
and lipid regulation and is a major target organ of TH, which regulates the 
expression of genes involved in these important physiological processes [65, 
66]. However, the mechanism by which TH regulates the expression of these 
genes, whether by direct actions on transcriptional activity or by indirect actions 
on mechanisms that control cellular levels of mRNAs, is not well understood. 
Considering the importance of TH in regulating fundamental processes 
governed by hepatic function, and the potential importance of miRNAs in 
regulating genes coding for proteins important in this function, the hypothesis 
that TH regulates specific miRNAs was made.  
To explore this fact,  AML 12 cells derived from mouse hepatocytes were 
treated with a thyroid hormone. The RNA was extracted by treated and not 
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treated cells and the microarray hybridization was performed. As a result, a 
dataset including 4 samples and 6555 microRNAs was obtained and used as 
input for the algorithm. The differential expression between the two defined 
groups, treatment and control, each one being composed by two samples, was 
of interest. 
 
Case study 3 
All in vitro experiments were performed with C2C12 cell line. C2C12 is a mouse 
myoblast cell line able to differentiate in myotubes under particular conditions 
[67]. C2C12 expresses the transcription factor TBX5, and other proteins that are 
able to interact with TBX5, that is NKX2.5 and GATA4. For this reason this cell 
line is appropriate to study the TBX5 role in cell context. Tbx5 has a role in the 
development of the cardiac conduction system [68]. Mutations in several human 
T-box genes cause dominant disorders with a variety of developmental 
malformations. In humans, haploinsufficiency of functionally null TBX5 
mutations causes Holt–Oram syndrome [69], manifest by congenital heart 
defects, conduction-system abnormalities and upper-limb deformities.  
C2C12 cells were transfected with a plasmid codifying mouse TBX5 sequence.  
Moreover, other C2C12 cells were transfected with 2 ng of p-CMV, a control 
plasmid with CMV promoter (citomegalovirus promoter) but without any 
codifying protein sequence. 
After the proper controls of expression and functionality of TBX5 protein, a 
miRNOMA was done in order to investigate the miRNAs modulated as a 
consequence of TBX5 overexpression.  
Three miRNOMAs were created with the RNA from three distinct experiments. 
For each experiments we obtained two RNAs: the control, that is represented 
by cells transfected with p-CMV and the sample represented by cells 
transfected with p-TBX5.  
After the hybridization, a dataset including 6 samples  and 6555 microRNAs 
was obtained and used as input for the algorithm. The samples included three 
replicates of the treatment (sample 2, sample 4 and sample 6) and three 
replicates of the control (sample 1, sample 3 and sample 5). The assessment of 
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the differential expression between the two defined groups of replicates was the 
aim of this case study. 
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3 Algorithm for Illumina MicroRNA 
Microarray data analysis 
 
3.1 introduction 
The algorithm developed for the Illumina MicroRNA Microarray data analysis 
includes two steps: 
- pre-processing; 
- analysis of differential expression.  
 
 
3.2 Pre-processing  
The uniqueness of Illumina microarray design makes the data preprocessing 
significantly different from other types of microarrays. 
The preprocessing comprises two steps, described below. 
 
3.2.1 Variance stabilization 
Generally, larger intensities tend to have larger variations when repeatedly 
measured. This violation of a constant variance across the measurement range, 
which is described as ‘heteroskedasticity’ in statistics, imposes a serious 
challenge when applying canonical linear models or analysis of variance 
(ANOVA) to microarray data [5]. So that these well-established and well-
understood statistical models can be applied to microarray data, a data 
transformation strategy is usually applied to abrogate or at least reduce the 
heteroskedasticity. 
Three different methods are applied. 
 
Base-2 logarithmic transformation (log2) 
The base-2 logarithmic transformation of raw data is the most frequently used 
approach. The main advantages are the simplicity and the fact that fold-
changes of any given size appear as shifts of constant amount for all 
oligonucleotides. However, the logarithmic transformation has the tendency to 
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inflate variances when the intensities are close to zero although it stabilizes the 
variances at higher intensities. 
 
Cubic root 
This is a weaker transformation compared to the log2 transformation. Generally 
the cubic root does not stabilize the variance for the probes with high ranking 
(high-intensity signals) [4]. 
 
VST 
The variance-stabilizing transformation (VST) method has been expressly 
developed for the Illumina microarray and takes advantage of all of the 
information present in an Illumina microarray experiment, in particular the larger 
number of technical replicates [4]. 
The procedure for VST comprises different steps, described in the sequel. 
1. Selection of the background probes. The background probes are those with 
nonsignificant detection P-values (higher than a predefined P-value threshold, 
0.01 by default). 
2. Estimate of the variance of the background noise, c3, by taking the mean of 
the expression variance of the background probes. The bead to-bead 
measurement variation of each probe in each microarray is modeled assuming 
a general measurement model with both additive and multiplicative errors, 
widely used in analytical chemistry [70]: 
 
εµα η ++= eY
         (3.1) 
 
where Y is the measured intensity value; α is the offset; µ is the noise-free value 
in arbitrary units; and ε and η are additive and multiplicative error terms, 
respectively, which are assumed to be independent and Gaussian-distributed 
with zero mean. The mean (u) and the variance (v) of measurement Y can be 
estimated by: 
 
µα ηmuYE +==)(              (3.2) 
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222)( εη σµ +== svYVar  
 
where ηm  and 2ηs  are the mean and the variance of ηe , respectively, and  εσ is 
the standard deviation of ε. 
Substituting  µ with its estimate, the relationship between u and v can be 
derived. It can be expressed in a quadratic form: 
 
321
222 )()()/()( ccucumsuv ++=+−= εηη σα            (3.3) 
 
Equation 3.3 indicates an undesirable dependency of intensity variance on the 
mean, making the VST necessary to facilitate subsequent data analysis, which 
usually assumes that v and u are independent. 
3. Estimate of the parameters c1, c2 and c3. Assuming that the probes with non-
significant detection P-values (output by Illumina BeadStudio) measure the 
background noise, c3 can be estimated by taking the mean of the variance of 
these background probes. Therefore, c1 and c2 can be directly estimated by a 
linear fitting: 
 
213)( cuccuv +=−          (3.4) 
 
This procedure improves the reliability and robustness of the estimation of c1 
and c2, since the dynamic range of the standard deviation is much smaller than 
the variance. 
4. Computation of the transformed value h(y). It is expected to find a 
transformation function h for Y, Ỹ, such that the variance Var(Ỹ) of transformed 
Ỹ does not depend on the mean E(Ỹ). By using the delta method, the 
asymptotic VST function h can be derived as [71]: 
 
duuvyh
y
∫= )(/1)(           (3.5) 
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Substituting c1, c2 and c3 into Equation 3.5  yields: 
 
            (3.6) 
 
Equation 3.6 indicates that the log transform is a special case for h(y) when 
c3=0 or when the intensity measurement is large and c3>0. 
 
3.2.2 Normalization 
The need for normalization arises naturally when dealing with experiments 
involving multiple arrays. There are two broad characterizations that can be 
used for the type of variation one might expect to see when comparing arrays: 
interesting variation and obscuring variation. Biological differences, for example 
large differences in the expression level of particular  microRNAs between a 
diseased and a normal tissue source, could be classified as interesting 
variation. However, observed expression levels also include variation that is 
introduced during the process of carrying out the experiment, which could be 
classified as obscuring variation. This obscuring variation has several sources 
such as differences in sample preparation (for instance labeling differences), 
production of the arrays and processing of the arrays (for instance scanner 
differences). The purpose of normalization is to deal with this obscuring 
variation [72] . 
Three different methods are applied. 
 
Quantile 
The goal of the quantile method is to make the distribution of probe intensities 
for each array in a set of arrays the same. The method is motivated by a 
principle underlying the quantile-quantile plot. The quantile-quantile plot is a 
probability plot for comparing two probability distributions by plotting their 
quantiles against each other. A point (x,y) on the plot corresponds to one of the 
quantiles of the second distribution (y-coordinate) plotted against the same 
quantile of the first distribution (x-coordinate). Thus the line is a parametric 




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>+
=
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curve with the parameter which is the interval for the quantile [73]. The idea is 
that the distribution of two data vectors is the same if the plot is a straight 
diagonal line and not the same if it is other than a diagonal line. This concept is 
extended to n dimensions so that if all n data vectors have the same 
distribution, then plotting the quantiles in n dimensions gives a straight line 
along the line given by the unit vector 





nn
11
.....,,......... . 
This suggests that it is possible to make a set of data have the same distribution 
if the points of the n dimensional quantile plot are projected onto the diagonal. 
Let qk=(qk1, . . . , qkn) for k=1, . . . , p be the vector of the kth quantiles for all n 
arrays and 





=
nn
d 11 .....,,.........  be the unit diagonal. To transform from 
the quantiles so that they all lie along the diagonal, consider the projection of q 
onto d 
 








= ∑∑
==
n
j
kj
n
j
kjkd q
n
q
n
qproj
11
11
,.....,                    (3.7) 
 
This implies that the same distribution can be given to each array by taking the 
mean quantile and substituting it as the value of the data item in the original 
dataset. This motivates the algorithm for normalizing a set of data vectors by 
giving them the same distribution: 
1. given n array of length p, form X of dimension pXn where each array is 
a column; 
2. sort each column of X to give Xsort; 
3. take the means across rows of Xsort and assign this mean to each 
element in the row to get X’sort; 
4. get Xnormalized by rearranging each column of X’sort to have the same 
ordering as original X. 
The quantile normalization method is a specific case of the transformation xi’= 
F-1(G(xi)), where G is estimated by the empirical distribution of each array and F 
using the empirical distribution of the averaged sample quantiles [6].  
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The advantages of quantile normalization include the computational efficiency 
and the conservation of the rank order of microRNAs. However, the intensity 
transformation of a quantile normalization is discontinuous because the 
normalization forces the intensity values for different samples having exactly the 
same distribution. This would be most problematic in the tails where it is 
possible that a probe could have the same value across all the arrays. In 
practice, since probeset expression measures are typically computed using the 
value of multiple probes, this has found not to be a problem. 
 
Lowess (LOcally WEighted Scatter plot Smooth) 
The lowess method is based upon the idea of the ‘MA-plot’, where M is the 
difference in log expression values and A is the average of the log expression 
values, presented in Dudoit et al. [60]. M and A are calculated from probe 
intensities in two different arrays at a time.  
 
                            )(log,)/(log 212212 2
1
kkkkkk xxAxxM ==       (3.8) 
 
where k=1,2,…, p represents the probe, and xk1, xk2 are probe intensities in 
array 1, 2 respectively. A normalization curve is fitted to this M versus A plot 
using lowess. Lowess is a method of local regression introduced by Cleveland 
and Devlin in 1988 [74]. At each point in the data set a low-degree polynomial is 
fitted to a subset of the data, with explanatory variable values near the point 
whose response is being estimated. The polynomial is fitted using weighted 
least squares, giving more weight to points near the point whose response is 
being estimated and less weight to points further away. A user-specified input to 
the procedure called the "bandwidth" or "smoothing parameter" determines how 
much of the data is used to fit each local polynomial. α is called the smoothing 
parameter because it controls the flexibility of the lowess regression function. 
Large values of α produce the smoothest functions that wiggle the least in 
response to fluctuations in the data. The smaller α is, the closer the regression 
function will conform to the data. Using too small value of the smoothing 
parameter is not desirable, however, since the regression function will 
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eventually start to capture the random error in the data. Useful values of the 
smoothing parameter typically lie in the range 0.25 to 0.5 for most lowess 
applications. The value of the regression function for the point is then obtained 
by evaluating the local polynomial using the explanatory variable values for that 
data point. The Lowess fit is complete after regression function values are 
computed for each of the n data points. The fits based on the normalization 
curve are  M°K  and thus the normalization adjustment is M’k=Mk-M°k. Adjusted 
probe intensities are given by: 
                               
''
''
,
kkkk MA
k
MA
k xx
2
1
2
2
1
1 22
−+
==         (3.9) 
 
Figure 3.1 summarizes the entire process.  
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Figure 3.1. Steps of lowess normalization: a) plot of logarithmic intensities in 
array 2 versus array 1; b) M vs. A Plot with lowess fit (f=0.40); c) values 
adjustment; d) plot of adjusted logarithmic intensities in array 2 versus array 1. 
 
To deal with more than two arrays, the method is extended to look at all distinct 
pairwise combinations. After looking at all pairs of arrays, a set of adjustments 
is applied to the set of arrays. Then the process is repeated. Typically, only 1 or 
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2 complete iterations through all pairwise combinations are needed to achieve 
useful results. However, because this method works in a pairwise manner, it is 
somewhat time consuming. 
In contrast to quantile method, the loess or spline normalization provides a 
continuous transformation. However, these methods cannot ensure that the 
rank of the probes remains unchanged across samples. Moreover, the loess 
normalization assumes the majority of the microRNAs measured by the probes 
are non-differentially expressed and their distribution is approximately 
symmetric, which may not be a good assumption. 
 
Robust Spline Normalization (RSN)  
The RSN method combines features from loess and quantile normalization 
methods [62]. A monotonic spline is used to calibrate one microarray to the 
reference microarray. To increase the robustness of the spline method, the 
contributions of probes of putatively differentially expressed genes are down-
weighted. The probe intensities that are from potentially differentially expressed 
microRNAs are heuristically determined as follows. First, a quantile 
normalization is run. Next, the fold-change of a gene measured by a probe 
based on the quantile-normalized data is estimated. The weighting factor for a 
probe is calculated based on a Gaussian window function.  
 
3.2.3 Quality control after preprocessing 
To make sure the data quality meets the requirement, two different plots are 
used. In particular, a comparison of the plots obtained before and after the 
execution of normalization can allow the improvements to be clearly seen. 
The first plot is the density plot. In probability and statistics, density estimation is 
the construction of an estimate, based on observed data, of an unobservable 
underlying probability density function. The unobservable density function is 
thought of as the density according to which a large population is distributed; 
the data are usually thought of as a random sample from that population. The 
most basic form of density estimation is a rescaled histogram [75]. 
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The second plot is the box plot. A box plot or boxplot is a convenient way of 
graphically depicting groups of numerical data through their five-number 
summaries (figure 3.2):  
- smallest observation (sample minimum),  
- lower quartile (Q1),  
- median (Q2),  
- upper quartile (Q3),  
- largest observation (sample maximum).  
A boxplot may also indicate which observations, if any, might be considered 
outliers [76]. 
 
 
Figure 3.2. Box plot. 
 
 
3.3 Differential Expression Analysis 
An approach called “linear models” is used to analyze designed microarray 
experiments  [60]. Before its application, data must be opportunely adapted and 
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some matrices must be created. So, a step of data preparation is needed before 
the effective application of the statistics for differential expression study. The 
steps of data preparation and adjustment are described in the subsection 3.3.1. 
The linear models approach allows very general experiments to be analyzed 
just as easily as a simple replicated experiment.  The general philosophy is as 
follows.  The first step is to reset the hierarchical model of Lönnstedt and Speed 
[77] in the context of general linear models with arbitrary coefficients and 
contrasts of interest. The second step is to derive consistent, closed form 
estimators for the hyperparameters using the marginal distributions of the 
observed statistics. The estimators have robust behavior even for small 
numbers of arrays and allow for incomplete data arising from spot filtering or 
spot quality weights. The third step is to reformulate the posterior odds statistic 
in terms of a moderated t-statistic in which posterior residual standard 
deviations are used in place of ordinary standard deviations.  This approach 
results in a shrinkage of the microRNA-wise residual sample variances towards 
a common value, resulting in a more stable inference when the number of 
arrays is small.  The use of moderated t-statistic has the advantage over the 
posterior odds of reducing the number of hyperparameters which need to be 
estimated. The moderated t inferential approach extends to accommodate tests 
involving two or more contrasts through the use of moderated F –statistics [78]. 
The approach is fully described in the subsection 3.3.2. 
 
3.3.1 Data preparation 
The steps of data preparation and adjustment are indicated below. 
1. Removal of unexpressed microRNAs.  
The unexpressed microRNAs are those with a detection P-value >  0.01. They 
are removed in order  to speed up the processing and reduce the false 
positives.  
2. Construction of the “Data Matrix”. 
This is a matrix with N rows and M+1 colums with: 
- N=number of selected microRNAs; 
- M= number of samples.  
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The matrix reports the mean expression intensity of the selected microRNAs 
(which names are indicated in the first column) for each sample.  
3. Specification of sample types (design matrix).  
The design matrix indicates which “condition” (i.e. control, treatment) has to be 
applied to each array. Each row of the design matrix corresponds to an array in 
the experiment and each column corresponds to a coefficient which is used to 
describe the RNA sources in the experiment.  For example, if 4 arrays or 
samples (1, 2, 3, 4) are available and there are two samples per condition 
(control: 1 and 3 and treatment: 2 and 4), the correspondent design matrix is:  
 
 
 
 
Obviously, for each defined group the mean of the expression values of the 
samples making it up is taken. 
4. Specification of the comparisons that have to be performed.  
 
3.3.2 Linear models and moderated t-statistics for Microarray Data 
The design of any microarray experiment can be represented in terms of a 
linear model for each microRNA [78]. The response vector for the gth micro 
produced  by a set of n microarrays is ),.....,( gngTg yyy 1= .  
The linear model is as follows: 
 
gg XyE α=)(        (3.10) 
 
where X is the design matrix of full column rank and αg is a coefficient vector.  It 
is assumed: 
 
2
ggg Wy σ=)var(        (3.11) 
 
> design 
     cont   treat 
1      1        0 
2      0        1 
3      1        0 
4      0        1 
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where Wg is a known non-negative definite weight matrix. The vector yg may 
contain missing values and the matrix Wg may contain diagonal weights which 
are zero. 
The contrasts of the coefficients which are assumed to be of biological interest 
are defined by: 
 
g
T
g C αβ =         (3.12) 
 
It is of interest to test whether individual contrast values βgj are equal to zero.   
There may be more or fewer contrasts than coefficients for the linear model, 
although if more then the contrasts will be linearly dependent.   
The linear model is fitted to the responses for each microRNA to obtain 
coefficient estimators gα
)
, estimators 2gs  of 2gσ  and estimated covariance 
matrices:  
 
2
ggg sV=)var(α
)
         (3.13) 
 
where Vg is a positive definite matrix not depending on 2gs . The contrast 
estimators are:  
 
g
T
g C αβ )
)
=        (3.14) 
 
with estimated covariance matrices: 
 
2
gg
T
g CsVC=)var(β
)
      (3.15) 
 
The responses yg are not necessarily assumed to be normal and the fitting of 
the linear model is not assumed to be least squares. However the contrast 
estimators are assumed to be approximately normal with mean βg and 
covariance matrix 2ggT CVC σ  and the residual variances 2gσ  are assumed to 
follow approximately a scaled chisquare distribution.  The unscaled covariance 
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matrix Vg may depend on αg, for example if robust regression is used to fit the 
linear model. If so, the covariance matrix is assumed to be evaluated at  gα
)
 and 
the dependence is assumed to be such that it can be ignored to a first order 
approximation. 
Let vgj be the jth diagonal element of CTVgC. The distributional assumptions 
made about the data can be summarized by:  
 
),(, 22 ggjgjggjgj vN σβσββ ≈
)
       (3. 16) 
 
and: 
 
2
2
22
gd
g
g
gg d
s χσσ ≈          (3.17) 
 
where dg is the residual degree of freedom for the linear model for microRNA g. 
Under these assumptions the ordinary t-statistic 
 
gjg
gj
gj
vs
t
β)
=         (3.18) 
 
follows an approximate t-distribution on dg degrees of freedom. 
Given the large number of microRNA-wise linear model fits arising from a 
microarray experiment, there is a pressing need to take advantage of the 
parallel structure whereby the same model is fitted to each oligonucleotide. A 
simple hierarchical model which in effect describes this parallel structure can be 
applied. The key is to describe how the unknown coefficients βgj and unknown 
variances 2gσ  vary across microRNAs. This is done by assuming prior 
distributions for these sets of parameters. 
Prior information is assumed on 2gσ  equivalent to a prior estimator 20σ  with d0 
degrees of freedom, i.e., 
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≈        (3.19) 
 
This describes how the variances are expected to vary across microRNAs.  For 
any given j, it is assumed that a βgj is non zero with known probability 
jgj pP =≠ )( 0β . Then pj is the expected proportion of truly differentially 
expressed microRNAs.  For those which are nonzero, prior information on the 
coefficient is assumed equivalent to a prior observation equal to zero with 
unscaled variance v0j, i.e. 
 
),(, 20
2 00 gjgjggj vN σβσβ ≈≠        (3.20) 
 
This describes the expected distribution of log-fold changes for genes which are 
differentially expressed. Apart from the mixing proportion pj , the above 
equations describe 
a standard conjugate prior for the normal distributional model assumed.  In the 
case of replicated single sample data, the model here is a reparametrization of 
that proposed by Lönnstedt and Speed [77]. The parametrizations are related 
through dg=f, vg=1/n, d0=2ν, 20σ =a/(d0 vg) and v0=c where f, n, ν and a are as in 
[77]. For the calculations in this context the above prior details are sufficient and 
it is not necessary to fully specify a multivariate prior for the βg.  
Under the above hierarchical model, the posterior mean of 2−gσ  given 2gσ  is 2−gs~  
with: 
 
g
gg
g dd
sdsd
s
+
+
=
0
22
002~
          (3.21) 
 
The posterior values shrink the observed variances towards the prior values 
with the degree of shrinkage depending on the relative sizes of the observed 
and prior degrees of freedom. So, the moderated t-statistic can be defined as: 
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         (3.22) 
 
This statistic represents a hybrid classical/Bayes approach in which the 
posterior variance is substituted into to the classical t-statistic in place of the 
usual sample variance. The moderated t reduces to the ordinary t-statistic if 
d0=0. The moderated t is shown to follow a t-distribution under the null 
hypothesis H0: βgj=0 with degrees of freedom dg+d0. The added degrees of 
freedom for gjt~ over gjt  reflect the extra information which is borrowed, on the 
basis of the hierarchical model, from the ensemble of microRNAs for inference 
about each individual microRNA. This distributional result assumes d0 and 20σ  
to be given values. In practice these values need to be estimated from the data.  
 
3.3.3 Parameters estimation 
The parameters can be estimated from the data. In fact, consistent, closed form 
estimators for d0, s0 and v0j from the observed sample variances and 
moderated t-statistics are developed.  
Specifically, d0 and 20s  are estimated by equating empirical to expected values 
for the first two moments of log 2gs . The logarithm is used because the moments 
of log 2gs  are finite for any degrees of freedom and because the distribution of 
log 2gs is nearly normal so that moment estimation is likely to be more efficient.  
It can be written: 
  
2
gg sz log=         (3.23) 
 
Each 2gs  follows a scaled F-distribution so zg is distributed as a constant plus 
Fisher’s z distribution [79].  The distribution of zg is roughly normal and has finite 
moments of all orders including 
 
)/log()/()/(log)( ggg ddddszE 00
2
0 22 +−+= ψψ         (3.24) 
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and 
 
)/(')/(')var( 22 0ddz gg ψψ +=          (3.25) 
 
where ψ() and ψ’() are the digamma and trigamma functions respectively. It is 
defined: 
 
)/log()/()/( 222 0 gggg dddze +−−= ψψ         (3.26) 
 
Then: 
 
)/log()/(log)( 22 00
2
0 ddseE g +−= ψ         (3.27) 
 
and 
 
  3.29 { } )/(')/(')/()( 221 02 ddGGeeE gg ψψ ≈−−−           (3.28) 
 
Moreover, d0 can be estimated by solving 
 
{ })/(')/()()/(' 212 20 gg dGGeemeand ψψ −−−=          (3.29) 
 
for d0. Although the inverse of the trigamma function is not a standard 
mathematical function, equation 3.29 can be solved very efficiently using a 
monotonically convergent Newton iteration. 
Given an estimate for d0, 20s  can be estimated by: 
 
{ })/log()/(exp 22 0020 ddes −+= ψ        (3.30) 
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These estimators allow for dg  to differ between microRNAs and therefore allow 
for arbitrary missing values in the expression data.  Moreover, any microRNA 
for which dg=0 will receive 202 ssg =~ .  
The estimate of v0j is made by equating the order statistics of the | gjt~ | to their 
nominal values. Each order statistic of the gjt
~ yields an individual estimator of 
v0j . A final estimator of v0j is obtained by averaging the estimators arising from 
the top Gpj/2 of the order statistics where G is the number of microRNAs. 
 
3.3.4 Posterior odds and estimation of pj 
The ratio of the probability of an event's occurring to the probability of its not 
occurring. 
The posterior odds than any particular microRNA g is differentially expressed 
can be computed with respect to contrast βgj. The odds that the gth gene has 
non-zero βgj is: 
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since gjt~  and 
2
gs  are independent and the distribution of 
2
gs  does not depend on 
βgj. 
Substituting the density for gjt~  (the demonstration of the density calculation is 
not shown here) gives: 
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In the limit for d0 + dg large, the odds ratio reduces to: 
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This expression is important for accurate computation of Ogj in limiting cases. 
Following Lönnstedt and Speed [77], the statistic 
 
gjgj Olog=β          (3.34) 
 
is on a friendly scale and is useful for ranking microRNAs in order of evidence 
for differential expression. Note that βgj is monotonic increasing in gjt~ if the dg 
and vg do not vary among microRNAs.  
The proportions pj can be estimated from the data as well as the other 
hyperparameters. A natural estimator would be to iteratively set: 
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        (3.35) 
 
since Ogj/(1 + Ogj) is the estimated probability that microRNA g is differentially 
expressed, 
and there are other possibilities such as maximum likelihood estimation.  
Finally, the microRNA  j is differentially expressed when the correspondent pj is 
lower than a predefined cut-off. 
 
3.3.5 Multiple testing corrections 
Multiple testing corrections adjust p-values derived from multiple statistical tests 
to correct for occurrence of false positives. In microarray data analysis, false 
positives are oligonucleotides that are found to be statistically different between 
conditions, but are not in reality. A typical microarray experiment measures 
several thousand microRNAs simultaneously across different conditions. When 
testing for potential differential expression across those conditions, each 
microRNA is considered independently from one another. In other words, a 
moderated t-test or ANOVA is performed on each microRNA separately. The 
Meloni Antonella                                                                                             Part II           
 
144 
incidence of false positives (or microRNAs falsely called differentially expressed 
when they are not) is proportional  to  the  number  of  tests  performed  and  
the  critical  significance  level  (p-value cutoff).   
In practice, when a two-sample t-test is performed on a microRNA, the 
probability by which  
the microRNA’s expression level will be considered significantly different 
between two groups of samples is expressed by the p-value. The p-value is the 
probability that a microRNA’s expression level is different  between the two 
groups due to chance. A p-value of 0.05 signifies a 5% probability that the 
microRNA’s mean expression value in one condition is different than the mean 
in the other condition by chance alone. If 10,000 microRNAs are tested, 5% or 
500 microRNAs might be called significant by chance alone.  
This is why it is important to correct the p-value of each microRNA when 
performing a statistical test on a group of microRNAs. Multiple testing correction 
adjusts the individual p-value for each microRNA to keep the overall error rate 
(or false positive rate) to less than or equal to the user-specified p-value cutoff 
or error rate. 
Different types of multiple testing corrections are available and they are 
described in more detail below.   
 
Bonferroni correction  
The p-value of each microRNA is multiplied by the number of microRNAs in the 
microRNA list. If the corrected p-value is still below the error rate, the microRNA 
will be significant:  
Corrected P-value= p-value * n (number of genes in test) <0.05. 
As a consequence, if testing 1000 genes at a time, the highest accepted 
individual p-value is 0.00005, making the correction very stringent.  
 
Bonferroni Step-down (Holm) correction  
This correction is very similar to the Bonferroni, but a little less stringent [80]. 
1)  The p-value of each microRNA is ranked from the smallest to the largest.   
2)  The first p-value is multiplied by the number of microRNAs present in the 
microRNA list: if the end value is less than 0.05, the microRNA is significant: 
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corrected p-value= p-value * n < 0.05. 
3)  The second p-value is multiplied by the number of microRNAs less 1:   
corrected P-value= p-value * (n-1) < 0.05. 
4)  The third p-value is multiplied by the number of microRNAs less 2:  
corrected P-value= p-value * (n-2) < 0.05. 
It follows that sequence until no microRNA is found to be significant.  
 
Benjamini and Hochberg (BH) correction  
The correction proposed by Benjamini and Hochberg [81] is based on the False 
Discovery Rate (FDR). FDR calls for controlling the expected proportion of 
falsely rejected hypotheses rather than controlling all falsely rejected 
hypotheses. It works as follows.   
1)  The p-values of each microRNA are ranked from the smallest to the largest.   
2)  The largest p-value remains as it is.  
3)  The second largest p-value is multiplied by the total number of microRNAs in 
microRNA list divided by its rank. If less than 0.05, it is significant: 
corrected p-value = p-value*(n/n-1) < 0.05, if so, microRNA is significant. 
4)  The third p-value is multiplied as in step 3:  
corrected p-value = p-value*(n/n-2) < 0.05, if so, microRNA is significant. 
And so on.  
As it can seen from the example above, the correction becomes more stringent 
as the p-value decreases, similarly to the Bonferroni Step-down correction. This 
method provides a good alternative to Family-wise error rate methods. The 
error rate is a proportion of the number of called microRNAs. 
 
Benjamini & Yekutieli (BY) correction 
This is a modified FDR procedure. The BY method is acceptable with 
dependent tests and is calculated with a predetermined p-value that is divided 
by a quantity related to the number of hypothesis tests. The critical value is 
determined by: 
∑
=
−
n
i i
valuep
1
1
/  
Meloni Antonella                                                                                             Part II           
 
146 
The Bonferroni correction  is the most stringent  test of all. The more stringent a 
multiple testing correction, the less false positive microRNAs are allowed. The 
trade-off of a stringent multiple testing correction is that the rate of false 
negatives (microRNAs that are called non-significant when they are) is very 
high.   
The default multiple testing correction is the BH. It is the least stringent of all 
corrections and provides a good balance between discovery of statistically 
significant microRNAs and limitation of false positive occurrences.  
 
3.3.4 The toptable 
A table of the top-ranked microRNAs (toptable) is extracted from the linear 
model fit. The toptable is a dataframe with N rows (a row for each of the N 
selected microRNAs) and the following columns:  
 list of microRNAs; 
 average log2-expression for the probes over all arrays; 
 estimate of the log2-fold-change ; 
 moderated t-statistic; 
 raw p-value; 
 adjusted p-value or q-value. 
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4 Results 
 
4.1 Comparison of different pre-processing methods in relation to 
differential expression analysis 
The choice of a particular pre-processing method directly affected the 
expression values as well as the calculated fold changes. In fact, different pre-
processing approaches led to different fold-changes. Moreover, depending on 
the normalization procedure, some microRNAs appeared clearly regulated with 
a fold change greater than two or not regulated with a fold change close to one. 
Despite this difference in the values, the sign of the fold change for each 
microRNA was always the same, irrespective of the pre-processing approach. 
This indicated an equal capability to find out if the microRNA expression 
intensity was decreased or increased in the treatment versus the control group.  
Similarly, not corrected P-values (i.e., the significance level of changes 
detected) in the investigated data sets depended on the pre-processing 
procedure. Thus, microRNAs may have a very significant P-value after one pre-
processing method but not after another. Table 4.1 is the summary table for 
comparing different methods regarding their effects on the identification of 
differentially-expressed microRNAs. It shows the estimated number of 
significant genes for different group pairs.  
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Table 4.1. Number of significant microRNAs (p<0.05 in the moderate t-statistics) 
depending on the combination of different variance stabilization and 
normalization methods. 
N of miRNAs differentially 
expressed Method 
DB 1 
Variance 
stabilization Normalization G2-g1 G3-g1 
DB 2 DB 3 
log2  59 16 5 16 
  cubic-root  82 25 9 16 
  vst  
quantile 
58 14 6 15 
log2  51 36 4 13 
  cubic-root  51 52 10 9 
  vst  
loess 
67 26 4 12 
log2  63 10 5 20 
  cubic-root  56 36 11 22 
  vst  
rsn 
66 6 5 12 
 
 
4.2 Effect of multiple comparison correction 
After the application of the default multiple testing correction (Benjamini and 
Hochberg  False Discovery Rate) very few or no microRNAs passed the 
statistical restriction (Table 4.2). This is because the multiple testing corrections 
depend on how many oligonucleotides are tested. Therefore, the larger the list 
is, the more stringent the correction will be.  
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Table 4.2. Number of significant microRNAs (p<0.05 in the moderate t-
statistics) after the application of the BH multiple testing correction method 
depending on the combination of different variance stabilization and 
normalization methods. 
N of miRNAs differentially 
expressed Method 
DB 1 
Variance 
stabilization Normalization G2-g1 G3-g1 
DB 2 DB 3 
log2  37 0 0 0 
  cubic-root  0 0 0 0 
  vst  
quantile 
36 0 0 0 
log2  38 0 0 0 
  cubic-root  0 0 0 0 
  vst  
loess 
38 0 0 0 
log2  36 0 0 0 
  cubic-root  0 0 0 0 
  vst  
rsn 
32 0 0 0 
 
 
 
4.3 Validation by PCR Real Time 
For the comparison between g3 and g1 in DB1, the validation by PCR was 
possible only for two microRNAs. The first microRNA, miR-17 5p, resulted to be 
down-expressed in the treated sample vs the control while the second 
microRNA, miR-29b, was instead over-expressed. For both microRNAs, the 
direction of change in expression detected with the microarray analysis was in 
agreement with the PCR, regardless to the preprocessing approach. Fold 
changes determined  by  qrt-PCR  were  significantly greater than fold change 
assessed for the same microRNAs by microarray analysis. This is in agreement 
with other studies present in the literature in which microarray data results were 
compared to PCR results [82, 83].  
For the comparison between the treatment and control group in DB3, the 
validation by PCR was performed for four microRNAs: miRNA-150, miRNA-
712*, miRNA-181c and miRNA-181d. The first two microRNAs  resulted up-
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regulated and the last two down-regulated. Even in this case, the direction of 
change in expression detected with the microarray analysis was in agreement 
with the PCR for all the micrRNAs, regardless to the preprocessing approach. 
Moreover, fold changes determined  by  qrt-PCR  were  significantly greater 
than fold change assessed for the same microRNAs by microarray analysis. 
 
 
4.4 Comparison among Normalization approaches 
For each database, the boxplot and the density plot before and after the 
normalization are shown hereinafter. 
 
Database 1 
Figure 4.1 shows the boxplot and the density plot for all the arrays in the DB 1 
before normalization. From the figure, it is possible to see a low variability 
among the arrays in terms of minimum and maximum values, that is no arrays 
had a significant larger spread of the expression levels than others. However, it 
can be observed that the median of expression levels varied across the sets, 
indicating that the central location of the data had different levels. Figures 4.2, 
4.3 and 4.4 show the boxplot and the density plot after the normalization based 
on quantiles, preceded by the three possible approaches of variance 
stabilization. The quantile normalization, regardless to the variance stabilization 
method, allowed the elimination of the variability among arrays. Figures 4.5, 4.6 
and 4.7 show the boxplot and the density plot after the lowess normalization 
preceded by the three possible approaches of variance stabilization while 
figures 4.8, 4.9 and 4.10 show the boxplot and the density plot after the rsn 
normalization preceded by the three possible approaches of variance 
stabilization. Neither lowess nor rsn normalization allowed the elimination of the 
variability among the arrays and the lowess determined an higher variability in 
terms of minimum and maximum values. 
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Figure 4.1. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
before normalization. 
 
 
 
 
Figure 4.2. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
after quantile normalization preceded by the  log-2 variance stabilazation 
approach. 
 
 
Meloni Antonella                                                                                             Part II           
 
152 
 
 
 
Figure 4.3. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
after quantile normalization preceded by the  cubic root variance stabilazation 
approach. 
 
 
 
 
Figure 4.4. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
after quantile normalization preceded by the vst variance stabilazation 
approach. 
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Figure 4.5. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
after lowess normalization preceded by the  log-2 variance stabilazation 
approach. 
 
 
 
 
Figure 4.6. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
after lowess normalization preceded by the cubic root variance stabilazation 
approach. 
 
 
Meloni Antonella                                                                                             Part II           
 
154 
 
 
 
Figure 4.7. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
after lowess normalization preceded by the vst variance stabilazation approach. 
 
 
 
 
Figure 4.8. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
after rsn normalization preceded by the  log-2 variance stabilazation approach. 
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Figure 4.9. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
after rsn normalization preceded by the cubic root variance stabilazation 
approach. 
 
 
 
 
Figure 4.10. Boxplot (left) and density plot (right) for all the arrays in the DB 1 
after rsn normalization preceded by the vst variance stabilazation approach. 
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Database 2 
Figure 4.11 shows the boxplot and the density plot for all the arrays in the DB 2 
before normalization. A variability among the array was present and it was 
completely eliminated by the quantile normalization (figures 4.12, 4.13 and 
4.14). Figures 4.15, 4.16 and 4.17 show the boxplot and the density plot after 
the loess normalization preceded by the three possible approaches of variance 
stabilization while figures 4.18, 4.19 and 4.20 show the boxplot and the density 
plot after the rsn normalization preceded by the three possible approach of 
variance stabilization. Neither loess nor rsn normalization allowed the 
elimination of the variability among the arrays, but in all the boxplots a more  
consistent spread of the data across arrays compared to the raw data boxplot 
can be seen. 
 
 
 
Figure 4.11. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
before normalization. 
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Figure 4.12. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
after quantile normalization preceded by the log-2 variance stabilazation 
approach. 
 
 
 
 
Figure 4.13. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
after quantile normalization preceded by the log-2 variance stabilazation 
approach. 
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Figure 4.14. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
after quantile normalization preceded by the vst variance stabilazation 
approach. 
 
 
 
 
Figure 4.15. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
after loess normalization preceded by the log-2 variance stabilization approach. 
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Figure 4.16. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
after loess normalization preceded by the cubic root variance stabilization 
approach. 
 
 
 
 
Figure 4.17. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
after loess normalization preceded by the vst variance stabilazation approach. 
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Figure 4.18. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
after rsn normalization preceded by the log-2 variance stabilazation approach. 
 
 
 
 
Figure 4.19. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
after rsn normalization preceded by the cubic root variance stabilazation 
approach. 
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Figure 4.20. Boxplot (left) and density plot (right) for all the arrays in the DB 2 
after rsn normalization preceded by the vst variance stabilization approach. 
 
 
 
Database 3 
Figure 4.21 shows the boxplot and the density plot for all the arrays in the DB 3 
before normalization. In the figure, it is possible to notice the variability among 
the arrays in terms of minimum and maximum values, of  interquartile  range 
and of median value. Figures 4.22, 4.23 and 4.24 show the boxplot and the 
density plot after the normalization based on quantiles, preceded by the three 
possible approaches of variance stabilization. The quantile normalization, 
regardless to the variance stabilization method, allowed the elimination of the 
variability among arrays. Figures 4.25, 4.26 and 4.27 show the boxplot and the 
density plot after the loess normalization preceded by the three possible 
approaches of variance stabilization while figures 4.28, 4.29 and 4.30 show the 
boxplot and the density plot after the rsn normalization preceded by the three 
possible approach of variance stabilization. Both these methods allowed the 
reduction of the variability among the arrays. In fact, the spread of the 
normalized expression levels showed an higher consistence across arrays, and 
a much lower interquartile range variability was detected. Furthermore, the level 
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of the median values across arrays was closer to a horizontal compared to the 
data without normalization, indicating less variability.  
 
 
 
Figure 4.21. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
before normalization. 
 
 
 
 
Figure 4.22. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
after quantile normalization preceded by the log-2 variance stabilization 
approach. 
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Figure 4.23. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
after quantile normalization preceded by the cubic root variance stabilization 
approach. 
 
 
 
 
Figure 4.24. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
after quantile normalization preceded by the vst variance stabilization approach. 
 
 
 
Meloni Antonella                                                                                             Part II           
 
164 
 
 
 
Figure 4.25. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
after lowess normalization preceded by the log-2 variance stabilization 
approach. 
 
 
 
 
Figure 4.26. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
after lowess normalization preceded by the cubic root variance stabilization 
approach. 
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Figure 4.27. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
after lowess normalization preceded by the vst variance stabilization approach. 
 
 
 
 
Figure 4.28. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
after rsn normalization preceded by the log-2 variance stabilization approach. 
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Figure 4.29. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
after rsn normalization preceded by the cubic root variance stabilization 
approach. 
 
 
 
 
Figure 4.30. Boxplot (left) and density plot (right) for all the arrays in the DB 3 
after rsn normalization preceded by the vst variance stabilization approach. 
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Conclusion 
This part of my thesis is focused upon the analysis of MicroRNA microarrays 
data. Microarays are used to detect microRNAs that are differentially expressed 
between different biological states, this way offering a fundamental tool to study 
the biological roles of microRNAs [47]. 
Analysis of microarray data involves many different steps and there is a wide 
range of software available for the analysis of microarrays. Bioconductor, which 
is a set of libraries for the statistical programming language R, [60] was chosen, 
principally because both Bioconductor and R are open source. Open source 
also means that the program can be modified and new features can be added.  
A specific kind of microarray was taken into account: the Illumina bead-based 
technology, which has become increasingly popular due to its high degree of 
replication and reported high data quality [58]. Due to the specific statistical 
nature of the Illumina summary data as means and standard deviations of 
subsets of measurements, a particular treatment is needed [57]. 
So, an algorithm able to perform the analysis of Illumina microRNA microarray 
data in a systematic and easy way was developed by integrating, modifying and 
adapting some commands available in different Bioconductor packages. The 
algorithm includes 2 parts. The first part is the pre-processing, which typically 
constitutes the initial (and possibly most important) operation in the analysis of 
data from any microarray experiment. The pre-processing comprises two steps: 
variance stabilization and normalization. Three alternative variance stabilization 
strategies (log2, cubic root and vst) and three alternative normalization 
approaches (quantile, loess and rsn) are available. So, considering all the 
possible combinations between variance stabilization and normalization 
strategies, 9 different ways to pre-process the data are obtained. The second 
part of the algorithm deals with the statistical analysis for the identification of 
differentially expressed microRNAs. Linear models and empirical bayes 
methods are used [78]. In practice, the posterior odds statistic is reformulated in 
terms of a moderated t-statistic in which posterior residual standard deviations 
are used in place of ordinary standard deviations.   
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The algorithm was applied to three real microRNA datasets, provided by the 
MicroRNA group of the Institute of Clinical Physiology in Pisa, in order to try it 
and accomplish other different purposes.  
One purpose was to investigate the influence of the use of different 
preprocessing methods on the discovery of differentially expressed microRNAs. 
All the proposed approaches were proven to be consistent in capturing the 
overall expression pattern of circulating miRNAs (up or down), but the 
expression values and the Fold changes depended  significantly on the 
preprocessing approach applied. Moreover, depending on the pre-processing 
method used, the number of microRNAs and the set of the microRNAs 
identified as differentially expressed from the same study was substantially 
different. A possible solution to solve this contrast may be the intersection of 
results, that is to consider as differentially expressed the microRNAs found to 
be differentially expressed with more than one method. It has been similarly 
shown for the genes that the identification of a feature (differentially expressed 
gene) by more than one method increases confidence in results obtained [84]. 
It should be stressed that in the evaluation of the effect of a particular 
preprocessing method on the number of differentially expressed microRNAs, 
the not-corrected P-values were taken into account. As shown in the results, 
after the Benjamini and Hochberg False Discovery Rate correction, few or no 
microRNAs passed the statistical restriction. So, for the purpose of this study it 
was easier to consider the P-values without any correction. However, when a 
person is interested in the biological significance of the obtained results the 
correction should be applied, even though no microRNAs result differentially 
expressed (microRNAs that pass a restriction without multiple testing correction 
might all be false positives, thus not significant at all). In this case, to improve 
the statistical results, different solutions can be adopted, such as to  increase 
the p-value cutoff or to select a smaller list of microRNAs to use with the 
analysis in order to reduce the number of comparisons.  
Results from microarrays need to be validated, mainly for two reasons: 1) to 
verify that the observed changes are reproducible in a larger number of 
samples, and 2) to verify that array results are not the result of problems 
inherent to the array technology. The Quantitative real-time PCR has become 
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the gold-standard for this purpose. Unfortunately, it was possible to validate a 
limited number of microRNAs and only for two of the three case studies. In all 
the microRNAs tested, microarray and PCR methods produced concordant 
results with respect to the direction of regulation (up or down), although 
variability was observed in the degree of fold changes. The strong concordance 
is indicative of  a good reliability of the algorithm.  
The last purpose was to compare the performance of different normalization 
methods. There are very few published reports comparing normalization 
techniques for microRNA microarray data [85] and none focused on Illumina 
platforms. So, this represents the first study comparing normalization 
techniques for Illumina microRNA microarray data. The density and the box 
plots of original and normalized data were created and used for visual 
comparison. For all the datasets, regardless to the variance stabilization 
approach applied before, the quantile method was really able to remove 
sources of variation between arrays of non-biological origin, resulting in the best 
normalization approach. This is an important finding even in view of the fact 
that, as previously pointed out, the pre-processing method used influence 
further downstream analysis to a great extent. A good solution should be to 
select and intersect the lists of microRNAs detected as differential expressed 
when the quantile is used to normalize the data in the pre-processing step. 
In concluding this thesis, it is important to underline that no mention has been 
made regarding the biological interpretation of the differential expression 
detected with the developed algorithm. This is because it was outside of the 
main goals and required specific expertise and knowledge. 
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